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CHAPTER ONE: Background
I. Introduction
The loss of blood flow to the brain is termed ischemia and the subsequent resumption of
blood flow is termed reperfusion.

Brain ischemia and reperfusion (I/R) occurs primarily

following resuscitation from cardiac arrest and/or stroke and presents one of the most significant
clinical challenges. At present, there are no clinically effective pharmacologic interventions to
halt brain damage following I/R. The major Aim of this dissertation will be to investigate
possible mechanisms involved in neuron death following brain I/R, which may potentially lead
to the development of effective therapies.
A second major facet of this dissertation will be to address the issue of stroke and
diabetes.

It is very well established clinically that stroke outcome in diabetic patients is

significantly worse than in non-diabetic patients. Diabetes has negative effects throughout the
whole body and multiple different causes have been attributed to worsened stroke outcome. As
both diabetes and ischemia are stress to cells, I hypothesize that the worsened damage following
ischemic stroke in diabetes is due to a cumulative or additive effect of each condition on
neuronal stress responses.
Neuronal death following brain I/R injury is a result of a variety of damage pathways5.
The focus of the work here is on a specific aspect of I/R injury: the persistent inhibition of
protein synthesis, or translation arrest (TA), which occurs in neurons in response to I/R injury.
TA is of significance because, as I discuss in detail below, it correlates with neuronal death1,2.
The purpose of this Dissertation is to investigate mechanisms of TA in the brain following focal
ischemia, with and without diabetes. There has been extensive research on persistent TA in
global models of brain I/R, whereas research in focal ischemia, as occurs in stroke, has not been
as extensive. Therefore, there is a need to further study mechanisms of TA in the focal model.
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After a thorough literature review, I have found no studies of the possible role of TA in worsened
stroke outcome in diabetics, making this line of investigation completely novel.
Below, I will review our current understanding of I/R brain injury and how diabetes
worsens outcome. I will discuss clinical outcomes, the major mechanisms, and especially focus
on TA following brain I/R. The most current ideas on TA link it to intracellular stress responses
and the formation of subcellular particles involved in mRNA metabolism such as stress granules
and mRNA granules.

My Background discussion will introduce my hypotheses about

mechanisms of prolonged TA following focal brain I/R and the possible effect of diabetes on
these mechanisms. In subsequent chapters I will present my study designs and results. The
Dissertation will close with a chapter discussing the significance of my finding in light of the
existent literature and in terms of new ideas about cell injury dynamics that are being developed
in our laboratory.
II. Brain Ischemia and Reperfusion Defined
Ischemia is a significant decrease or cessation of blood flow to the brain, and reperfusion
is resumption of normal or near normal blood flow. The brain is the most sensitive organ to I/R
injury. I/R brain injury takes two major forms: global and focal. Global ischemia is a cessation
of blood flow to the entire brain and occurs in humans during drowning or during cardiac arrest.
Focal ischemia is ischemia of a localized region of the brain and is due to many possible causes
such as artery occlusion, ruptured hematomas, gliomas, etc. Stroke is the focal ischemia that
most often occurs in humans. Both focal and global ischemias are lethal to neurons and there is
great clinical interest in determining the mechanisms of injury so as to be able to treat these
conditions.
III. Focal Ischemia and Reperfusion Brain Injury
Stroke is the most common form of focal ischemic insult to the brain and is the third most
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common cause of death and disability in the United States.3 Ischemic stroke accounts for
approximately 80% of all strokes and results from an embolic or thrombotic occlusion of a major
cerebral artery or its branches. This is most often the middle cerebral artery (MCA). Occlusion
of a specific blood vessel results in injury to the corresponding volume of brain tissue fed by the
occluded vessel. Loss of the brain functions associated with the ischemic brain volume occurs
rapidly. Damage to the brain results from either a transient ischemic attack, where neuronal
function will be restored ~24 hrs after the development of symptoms4, or from a stroke, where
neuronal function is lost forever due to irreversible death of the brain tissue.
Unlike global ischemia, which leads to neuronal cell death in very specific neuron
populations, there is a morphological complexity to stroke injury.5 Focal ischemia produces a
mass of damaged brain tissue termed the infarct. Damage is expressed as the volume of the
infarct. A necrotic core forms at the site of the occlusion, consisting of dead brain tissue
including neurons, glia and vascular tissue. Surrounding the core is a penumbra characterized by
hypoperfusion and other metabolic and functional disturbances. If the vessel remains occluded,
an increasing number of cells, further away from the core, will eventually be affected. These
cells define the penumbral region, and their death occurs many hours, days or in some cases,
months, after the initial ischemia.

Penumbral neurons that die after the ischemia are

distinguished from the immediate necrosis of the core by the term “delayed neuronal death”
(DND).6
In permanent ischemia, the initial infarct is seen after 3-12 hrs.7 The infarct begins in the
core but reaches close to its maximal size, which includes core and penumbra, 8-24 hrs after the
onset of ischemia. The infarct continues to grow after 1 day, so that between 24 and 72 hrs it can
grow by approximately 30%.8

Thus damage continues to increase in penumbral regions.

Different durations of temporary ischemia lead to graded involvement of different regions in the
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infarct as measured after 1-2 days reperfusion.9 Studies have demonstrated that 1 hr of ischemia
leads to infarct in the core, with infarct in the penumbra developing fully within 2-3 hr of
temporary occlusion.10 As little as 30 minutes of transient ischemia leads to an infarct in the core
region, but this only first appears after 3 days and takes 2-3 weeks to mature to its full size.11
Individual cell death within the infarct develops slowly, but more rapidly than delayed
cell death in global ischemia. Cell death first becomes significant at approximately 6-12 hrs in
the core of the lesion, with a major increase between these two time points. At 12 and 24 hrs,
approximately 80% of the neurons died.12 The final stage of infarct development in focal
ischemia is pan-necrosis, in which neuronal death is accompanied by glial and vascular cell
death and loss of cellular elements.5
To conclude, development of the necrotic infarct occurs within a few hours of focal
ischemia, but matures over up to several days, drawing in penumbral regions and resulting in a
larger mass of dead brain tissue.
IV. Diabetes and Worsened Stroke Outcome
A. Diabetes Defined
Diabetes mellitus is a metabolic disorder characterized with chronic degenerative changes
in various tissues, with the two major forms being type 1, insulin-dependent, and type 2,
noninsulin-dependent diabetes. In the United States, 25.8 million people, or 8.3 % of the
population, have diabetes, with 1.9 million new cases of diabetes diagnosed in people aged 20
years or older in 2010.13 Type 2 diabetes accounts for ~90% of the population diagnosed with
diabetes in the United States. Diabetes is not just an epidemic of the US but is considered a
global health problem, affecting over 340 million people worldwide.14
Type 1 diabetes is an autoimmune disorder characterized by the destruction of pancreatic
islet cells, including the insulin-producing beta cells. However, many factors contribute to the
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onset of type-2 diabetes, including genetic, lifestyle and dietary. Type 2 diabetes is characterized
by insulin resistance, relative insulin deficiency at later stages, and excessive hepatic glucose
production, all leading to hyperglycemia. The primary events are believed to be an initial deficit
in insulin secretion and, in many patients, relative insulin deficiency in association with
peripheral insulin resistance15. Dysfunction of pancreatic beta cells, which produce insulin, is
necessary for the development of the disease, but the nature of the primary beta cell defect is still
unknown.
Initiation of the insulin response depends upon the transmembranous transport of glucose
and coupling of glucose to the glucose sensor on the beta cell. The glucose/glucose sensor
complex then induces an increase in glucokinase by stabilizing the protein and impairing its
degradation.

The induction of glucokinase serves as the first step in linking intermediary

metabolism with the insulin secretory apparatus. Glucose transport in beta cells of type 2
diabetes patients appears to be greatly reduced, thus shifting the control point for insulin
secretion from glucokinase to the glucose transport system16. Other defects in beta cell function
in type 2 diabetes include defective glucose potentiation in response to substances that cause
non-glucose-dependent insulin secretion, asynchronous insulin release, and a decreased
conversion of proinsulin to insulin.
A hallmark of type 2 diabetes is increased secretion of insulin, hyperinsulinemia, early
on. In later stages, because of the chronic insulin resistance in muscle and adipose cells and
impaired beta cell function, there is a loss of the early insulin release in response to
hyperglycemic stimuli17. Thus, when insulin binds to its receptors, it is not able to bring about a
response of increased glucose utilization in these cells. With the impaired insulin production and
secretion, glucose synthesis and output from the liver increases. Thus, the liver in type 2
diabetes is programmed to both overproduce and under use glucose.
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Furthermore, in addition to the ineffectiveness of insulin in inhibiting glucose production
in the liver, free fatty acids are deposited into tissues and inefficiently stored in adipose tissue,
resulting in elevated circulating levels. The elevated FFA levels also lend to the increased
glucose production by the liver18. The ensuing glucose toxicity leads to a multitude of
disturbances in various tissues, disrupting homeostasis throughout the body.

Chronic

hyperglycemia and hyperlipidemia can exert deleterious effects on beta cell function. Over time,
both of these phenomena contribute to the progressive deterioration of glucose homeostasis
characteristic of this disease and various long-term complications. The long-term complications
markedly increase the susceptibility to cardiovascular disease, including ischemic stroke.
B. Impact of Diabetes on Stroke Occurrence and Recovery
People with diabetes are two to four times more likely to have an atherotherombotic
stroke than people who do not have the disease13. Diabetes particularly affects the risk of stroke
among younger individuals, with a more than 10-fold increase risk of stroke in the stroke
population younger than 55 years13. It has been demonstrated that diabetes is associated with
vascular alterations, including cerebrovascular atherosclerosis and other abnormalities19. There
is compromised collateral flow throughout arterial networks, leading to a decrease in blood flow
to the brain that further complicates stroke. In addition, people with diabetes often have high
blood pressure, which can also cause abnormalities in the small blood vessels of the brain and
contribute to the increased susceptibility to stroke. Because diabetes has the tendency to exert
such deleterious effects on the vascular system, these factors render diabetics, at least in part, to
be more susceptible to ischemic brain damage and worsened outcome following stroke.
In order to investigate the impact of diabetes on stroke, neuronal cell death was assessed
following permanent focal ischemia using the middle cerebral artery occlusion (MCAO)
technique. The infarct core includes the striatum and overlying cortex, areas directly fed by the
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MCA. Areas peripheral to the core encompass the piriformis and parietal cortex.20 However, the
hippocampus did not display an infarct and is therefore not considered to be in the core. As
explained above, the current understanding is that neuronal cell death is due to necrosis
occurring in the core and to DND in the penumbra.21 The core of the focal lesion undergoes
massive ion and metabolite changes that, by some indicators such as ATP levels and ion
gradients, appears to recover after transient ischemia. However, during the reperfusion period, it
is near impossible to prevent formation of an infarct in the core by any interventions, despite the
initial appearance of recovery.22
In contrast, in the MCAO model, the penumbra can be rescued by many
interventions5,122, indicating different mechanisms of damage in the two regions. This is why
defining the penumbra and the mechanisms by which neurons die in that region is of particular
interest. Terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) was
used to assess nucleosomal DNA fragmentation in situ in normal and diabetic animals with or
without MCAO22.

No TUNEL positive cells were found in the cortex of normal animals,

whereas the diabetic animals did show positive TUNEL staining in the cortical cells. After
permanent MCAO, TUNEL positive cells were present in the piriform and parietal cortices in the
normal animals and were further increased in the diabetic group. Furthermore, caspase-3 was
also found to be increased following MCAO in normal animals and was increased above that in
the diabetic group.22 Caspase 3 activation is most often associated with apoptosis, but in neurons,
its activation has also been associated with neuronal remodeling that is not associated with cell
death.23
These studies demonstrated that focal ischemia produces cell death in the core of the
infarct and ensuing cell death in the penumbral region, with the amount of cell death being
augmented by the presence of diabetes. To consider mechanisms by which diabetes worsens
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stroke outcome, we first turn to a discussion of the established mechanisms of brain I/R injury.
V. Established Mechanisms of Brain I/R
Following focal ischemia, the core is not salvageable. However, the DND associated
with the penumbra provides a time window for therapeutic interventions. Therefore, it is the
goal of stroke research to understand DND in the penumbra to be able to limit stroke damage to
only the core infarct. The DND of penumbra is very similar in both time course and mechanisms
to the DND found in selectively vulnerable neurons after global ischemia, and therefore, findings
in the global ischemia models are brought to bare on the focal case.
It needs to be emphasized that, in spite of a very large amount of information (a PubMed
search of the term “brain ischemia” gives 78,805 papers!), the cell death pathways causing DND
following I/R injury are not known with certainty. The “acid test” of current knowledge is the
fact that all pharmacologic clinical trials following either stroke122 or cardiac arrest and
resuscitation24 have fully failed. Therefore, it is safe to conclude our current knowledge, in spite
of its volume, is incomplete. It is anticipated that a full and correct understanding of DND will
lead to the development of clinically effective therapies. In the following paragraphs, we review
(1) the established damage mechanisms associated with I/R injury and (2) the stress response
expressed by neurons following I/R injury.
A. Ischemia
Ischemia, independent of reperfusion, brings about various forms of cell damage, all
surrounding the rapid loss of ATP, which is secondary to the loss of glucose and oxygen influx
following cessation of cerebral blood flow. In the brain, ATP loss most directly affects the
Na+/K+-ATPase electrogenic pump, accounting for approximately 50% of ATP utilization in the
neuron.25

Consequently, ATP loss in the brain leads to a series of events known as

excitotoxicity.
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1. Excitotoxicity
Under normal conditions in a neuron, the binding of glutamate to NMDA and AMPA
receptors causes depolarization of postsynaptic neurons via rapid influx of Na+ and Ca2+.
Depolarization also induces Ca2+ influx through the voltage gated L- and T- calcium channels.
This calcium influx is reversed when extra- and intracellular ion concentrations are reset,
ultimately via the Na+ gradient created by several ATP-dependent Ca2+ pumps. Also, continued
glutamate excitability is halted as a result of glutamate reuptake by astroglia, in an ATP
dependent manner.
Following ischemia, ATP levels drop in cells because of a lack of delivery of oxygen and
glucose and a high rate of ATP expenditure in these cells. ATP levels are 50% of baseline in the
first min of ischemia, and essentially zero at 4 min ischemia26. Loss of ATP halts the function of
the Na+-K+-ATPase allowing uncontrolled ion influx, mainly through “leak channels” initially,
and allowing ions to approach their Nernst equilibria. The net result of the attempt of ions to
equilibrate is a net depolarized state in the neuron. The depolarization results in the release of
excessive amounts of excitotoxic amino acids, namely glutamate, from presynaptic neurons into
the extracellular space.27 Glutamate then acts by activation of NMDA and AMPA receptors.
This leads to an uncontrolled positive feedback loop: net depolarization results in
neurotransmitter release, the majority of which are excitatory, inducing ligand-gated
depolarization, which causes further excitatory transmitter release, inducing further
depolarization. This feedback continues until releasable transmitter is depleted. This sequence
of events is called excitotoxicity.
Long durations of ischemia will cause such extreme ion equilibration that cells will die
by bursting due to a net ion influx carrying water by osmotic forces. However, with moderate
and clinically relevant ischemia durations, ion influx is not sufficient to burst cells, but leads to a
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pathologically high cytoplasmic Ca2+ concentration. Silver and Erecinska in 1990 demonstrated
that, during ischemia, intracellular Ca2+ concentration in neurons goes from about 10 nM to
about 800 nM after 7 min of complete ischemia28.
During focal ischemia, the impact of intra-ischemic depolarization is not completely
known. Previous studies have found that there is a wave-like spread of increased extracellular
K+ and glutamate from the core of the lesion in a phenomenon known as “spreading
depression”29. The frequencies of the depolarizations are halved by either AMPA or NMDA
antagonists, indicating that glutamate-mediated depolarization contribute at least 50%.30. The
evidence linking the development of damage in the penumbra to these depolarizations is
extensive, but mainly correlative31.

The most convincing direct evidence that these

depolarizations are damaging came about by using either KCl or electrical stimulation, which
increased the number of depolarizations by twofold. This resulted in an increase in the size of
the infarct and peri-infarct damage by 30-100%31-32. Based on these findings, the damage caused
by the induced depolarizations suggests that the endogenous depolarizations are also damaging
during ischemic conditions. However, pharmacological targeting, in an effort to more directly
establish the importance of the depolarizations, has proven to be difficult31.
The contribution of excitotoxicity to DND has not been resolved. One study has shown
significant ultrastructural alterations in post-synaptic densities following I/R that persisted to at
least 24 hr reperfusion in CA1 compared to dentate gyrus (DG)33. However, this study failed to
evaluate these parameters in CA3, which is also well known to have very high excitatory
transmission, which underlies the development of temporal lobe epilepsy34. Perhaps most
important, the extracellular levels of excitatory transmitters found in ischemic brain is much less
than those generated by exogenous application of the transmitters required to generate cell death
solely by an excitotoxic mechanism35. Thus, any notion that excitotoxicity is the sole factor in
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DND has been proven false. Other lines of evidence suggest that the main contribution of an
excitotoxic mechanism to DND is to allow a massive dys-regulation of cytoplasmic Ca2+.
B. Reperfusion Damage Mechanisms
Reperfusion results in additional damage mechanisms that compound the damage evoked
during ischemia. These include: free radical production, lipid peroxidation, nitrosylation, further
alterations in cellular signaling pathways, and persistent TA.
1. Free Radicals
There is substantial evidence that free radical damage (today commonly known as
reactive oxygen species or ROS) contributes to DND following brain I/R. One consequence of
the abnormal calcium influx in neurons during ischemia is a rapid increase in intracellular
arachidonic acid concentration by Ca2+-activated phospholipases36-37. Once reperfusion begins,
the accumulated arachidonic acid can be converted to hydroperoxides by lipoxygenase. The
hydroperoxides can participate in lipid peroxidation by Fenton-like reactions38. Thus, oxidative
damage occurs in reperfused neurons on the membrane as a result of lipid peroxidation39.
Oxygen supply to ischemic cells is restored with reperfusion. Oxygen is an essential
substrate of the enzyme cyclooxygenase which catalyzes the addition of two oxygen molecules
to arachidonic acid producing prostaglandin G. Prostaglandin G is subsequently peroxidized,
forming an oxygen radical, superoxide (O2-) and prostaglandin H26. While the prostaglandins are
known inflammatory mediators, they can also increase in lipid peroxidation in cell membranes
that will result in changes in lipid permeability and fluidity. This, in turn, will disrupt the
functions of receptors, ion channels, and other proteins located on the cell membrane.
Perturbations within the cell membrane occur as a result of the glutathione depletion during
ischemia40, resulting in the cell’s inability to recover from damage caused by lipid peroxidation.
In addition to reactive oxygen species, the oxygen radicals can react with nitric oxide
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(NO) through a reaction catalyzed by NOS, forming peroxynitrite19, a reactive nitrogen species
(RNS). Peroxynitrite, in turn, oxidizes Fe2+ ions resulting in greater lipid peroxidation41. In
addition, under ischemic conditions there is a resultant burst of free oxygen radicals and the
release of pro-apoptotic molecules due to the formation of mitochondrial permeability transition
pores42. Following ischemia, free radicals are generated during the inflammatory response43.
In focal ischemia, there is very little free radical change in the core as compared to the
penumbra; this is in contrast to the ion and metabolite changes that occur.44 Free radical
production, as measured by hydroxylation of salicylic acid, remained elevated 3 hours after the
onset of ischemia in the penumbra, and further elevated with the onset of reperfusion. In
contrast, there was no increase in the core during 3 hours of ischemia, but there was an increase
at about 4 hours reperfusion45. Therefore, core exposure to free radicals during the main periods
of injury development during ischemia is considered minimal with free radical production
largely restricted to the penumbra5.
In addition, studies have definitively shown that free radical and NO production are
elevated for at least 6-12 h following focal ischemia46. It has been demonstrated that elevated
levels of superoxide, in concert with NO production, result in increased peroxynitrite production.
It has been well established that free radicals are generated during and after both focal and global
ischemia and conditions that reduce their accumulation should ameliorate damage, if the free
radicals are in fact damaging. However, cell death, induced by arachidonate activation, in NB104 cells is not inhibited after cells were treated with radical scavengers47. But in the same study,
cell death induced by lipid hydroperoxides was prevented when treated with radical
scavengers47. Despite the apparent connection between oxygen radical formation and lipid
peroxidation in causing cell death, studies have proven otherwise. Although the contribution of
free radical damage to reperfusion injury is significant, it is only part of the picture.
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C. Inflammation
Inflammation has been implicated as a secondary injury mechanism following stroke. A
growing number of recent investigations have established a critical role for leukocytes in
bringing about tissue damage after ischemia and reperfusion in stroke. The vascular endothelium
promotes inflammation through the upregulation of adhesion molecules like intercellular
adhesion molecule (ICAM)-1, E-selectin, and P-selectin, that bind to circulating leukocytes and
facilitate their migration into the CNS48.

Once in the CNS, the production of cytotoxic

molecules may facilitate cell death. The macrophage and microglial response to injury may
either be beneficial by scavenging necrotic debris or detrimental by facilitating cell death in
neurons that would otherwise recover.
Using MCAO, several studies have demonstrated that inflammatory events occurring at
the blood-endothelium interface of cerebral capillaries underlie the resultant ischemic tissue
damage.

Inflammatory cell adhesion molecules, chemokines, and cytokines have all been

implicated in the pathogenesis of damage. Following transient and permanent MCAO, proinflammatory cytokines such as interleukin (IL)-1 and IL-6 act upon the vascular endothelium
to increase the expression of ICAM-1, P-selectin, and E-selectin, which promote leukocyte
adherence and accumulation.5 It has been shown that application or overexpression of the IL-1
receptor antagonist, IL-1r, reduces infarct size49 and blockage of IL-1 converting enzyme
reduces brain injury through decreased formation of IL-150
In addition, cell surface receptors called integrins are activated and mediate intracellular
inflammatory signals.

These inflammatory signals promote leukocyte migration across the

endothelium and mediate inflammatory cascades resulting in further cerebral damage. There is
also an accumulation of neutrophils, which are phagocytotic white blood cells, in infarcted tissue
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24 h after permanent or temporary focal ischemia51. Neutrophils have been observed within the
vessels and the parenchyma of ischemic brain after reperfusion52. Depletion of neutrophils from
the circulation using anti-neutrophil antibodies reduces the brain injury associated with ischemia
and reperfusion53, suggesting a causative, but minor, role for neutrophils in brain injury. Further
investigation of the underlying mechanisms of inflammation may play an important role in the
development of therapeutic treatment of stroke.
D. Post-Ischemic Translation Arrest
In 1971, Kleihaus and Hossmann discovered that during reperfusion, protein synthesis
was inhibited, in spite of return of normal ATP levels54. This post-ischemic translation arrest
(TA) has proven to be an important observation. Subsequently research established that: (1) TA
occurs in all post-ischemic brain regions for at least several hours1, (2) translation recovers in
surviving brain regions, but not in regions that will die by DND, and (3)
the TA appeared to involve a defect at the initiation stage of
translation1.Figure 1: TA after focal ischemia and reperfusion.
Figure 1 illustrates TA following focal ischemia induced by
MCAO in a study conducted by Dr. Wulf Paschen2. In this study,
following 2 hr MCAO and durations of reperfusion indicated in the
figure, animals were administered radioactive amino acid, and
autoradiograms

prepared.

Following

ischemia,

the

ipsilateral

hemisphere showed no protein synthesis in the MCA territory. In the
penumbral area of cerebral cortex, a slight recovery occurred at 6 hr Figure 1 : TA after
focal ischemia and
reperfusion, but by 24 hr reperfusion, the recovery was not sustained and reperfu-sion. Image
from2.
incorporation was lower than the 6 hr time point. The core lesion in the
basal ganglia never recovered translation because the cells were necrotic. But significantly,
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translation never recovered in the cortical penumbra and these neurons subsequently died.
VI. Translation Arrest and Brain I/R
For many years, TA was considered a damage mechanism induced by I/R injury.
However, continued work in this area has caused a shift in this viewpoint. Instead of being seen
as a damage mechanism, TA is now recognized as a marker of protective intracellular stress
responses, and the persistent TA that correlates with cell death is considered a symptom of a
dysfunctional stress response on the part of post-ischemic neurons. What I will do in this section
is first, discuss what has been discovered about the causes of TA during I/R, and then discuss
how these discoveries have linked post-ischemic TA with neuronal stress responses. I will
discuss the role of TA in the general response of cells to exogenous stressors. These ideas will
provide the basis for the dissertation work I proposed.
Most studies conducted on TA following I/R have used global ischemia models.
Therefore most of the evidence I will discuss will be based on global models. TA has been less
studied in focal models, and the experiments I will propose will be aimed precisely at clarifying
mechanisms of TA after focal ischemia, with and without diabetes.
A. Translation Initiation
Kleihaus and Hossmann54 in 1971 showed in their seminal study that polysomes
dissociated immediately with the onset of reperfusion and that protein synthesis was inhibited.
Because it was known even then that polysome dissociation was a marker of inhibition of
translation initiation, these authors inferred that translation initiation was inhibited in the
reperfused neurons. Much subsequent research investigated translation initiation following I/R
so I will now explain translation initiation.
Protein translation consists of three steps; initiation, elongation, and termination. More
than a dozen globular protein initiation factors are involved in the initiation step, working in
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concert to promote the binding of mRNA, the small 40S ribosomal subunit, the large 60S
ribosomal subunit, and the methionine-conjugated initiator tRNA. After the formation of the
initiation complex, initiation factors dissociate and elongation factors are recruited to allow the
ribosome to move on the mRNA in the 5’ → 3’ direction, by which the mRNA sequence is
translated into a primary protein sequence. A critical aspect of the elongation phase is the
binding of chaperone proteins to the nascent peptide, which help it to fold into its mature threedimensional tertiary conformation. The termination step takes place when a special tRNA binds
to a stop codon on the mRNA, signaling elongation termination and dissociation of the nascent
peptide.
There are two rate-limiting steps in translation initiation that serve as almost universal
regulatory targets, from bacteria, through yeast, to complex metazoans including humans. These
steps involve eIF2, which delivers the charged initiator tRNA and eIF4, which delivers the
mRNA to the 40S subunit. eIF4F is a heterotetramer, consisting of eIF4E, eIF4A, eIF4B, and
eIF4G subunits55. eIF4E binds the 5’ m7-G cap of the mRNA. eIF4A is a helicase that, in
association with its cofactor eIF4B, unwinds the secondary structure of the mRNA, allowing the
ribosome to scan the mRNA. Finally, eIF4G is a scaffold protein, providing a surface on which
many of these binding interactions occurs56.

eIF4 is controlled by several concurrent

mechanisms55 and the main result of eIF4 regulation is to control which mRNAs get translated.
eIF2 determines the global rate of protein synthesis and contributes to the initiation of
protein translation by forming a ternary complex with GTP and Met-tRNA. Binding of the
ternary complex to the small 40S ribosomal subunit forms the 43S preinitiation complex.
Addition of the mRNA-eIF4 complex forms the 48S preinitiation complex. Once initiation is
completed, the 60S large ribosomal subunit joins, and hydrolysis of eIF2-GTP to GDP occurs,
followed by the dissociation of eIF2 from the completed ribosomal 80S complex. The exchange
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of GDP bound to eIF2 for GTP is mediated by eIF2B, a guanine nucleotide exchange factor, and
is a crucial step for the recycling of eIF2. This is important because eIF2-GDP cannot bind the
methionyl charged initiator tRNA to form the ternary complex and prepare eIF2 for another
round of initiation. Thus, the quantity of available eIF2B is the rate-limiting factor for normal
rates of translation initiation.
Phosphorylation of the alpha subunit of eIF2 causes a decrease in total protein synthesis
rate. Mechanistically, when the alpha subunit of eIF2 is phosphorylated [eIF2(αP)], it binds
eIF2B with a much higher affinity than dephosphorylated eIF2.57 The sequestration of eIF2B by
eIF2(αP) effectively removes it from the reaction cycle. This in turn results in an accumulation
of eIF2-GDP that is not able to form the ternary complex and leads to the subsequent stalling of
ribosomes during initiation, while awaiting delivery of the initiator methionine.
There are two established mechanisms of eIF4F regulation: (1) by phosphorylation of
eIF4E, which increases its affinity for eIF4G, thereby increasing the formation of the eIF4
complex58 and (2) by 4E binding proteins (4EBPs), when dephosphorylated, compete with eIF4G
for binding to eIF4E, preventing the formation of eIF456.

eIF4G regulation is not well

understood, but what is known is that following infection with a picornavirus, eIF4G is
degraded59. The main effect of decreasing available eIF4 is a quantitative shift in which types of
mRNA are translated and a net decrease in protein translation59.
Fragmentation of eIF4G disables 5’-capped mRNAs to be delivered to the ribosome;
however uncapped viral mRNAs contain special nucleotide sequences in their 5’ untranslated
regions known as an internal ribosome entry site (IRES). The IRES allows cap-independent
translation of viral mRNAs60. In addition, degradation of eIF4G via caspase-3 proteolysis occurs
during apoptosis, where important apoptotic mRNAs such as the FAS receptor and DAP5 (an
eIF4G homolog) contain IRES sequences61.
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B. Changes in eIF2 and eIF4 during reperfusion
Studies of translation initiation following brain ischemia and reperfusion have revealed
that eIF2α is phosphorylated and eIF4G is degraded62,63,64,65,66.

In 2004, Garcia et al

demonstrated that eIF2α phosphorylation occurred with or without ischemic preconditioning
(IPC). IPC is an exposure to a brief, nonlethal duration of ischemia followed by a lethal dose
two days later.67 Cell death does not occur when IPC is performed68 and therefore, eIF2α(P)
itself is not directly involved in DND since it occurs with or without IPC. However, degradation
of eIF4G occurred only with long ischemia durations, while eIF2α(P) occurred even with the
shortest ischemia durations.
Studies of eIF2α(P) showed that it is a transient and acute response. While eIF2α(P)
occurs rapidly, it also dephosphorylated rapidly. Therefore, the consensus has emerged that
eIF2α(P) cannot be responsible for the prolonged TA associated with DND2,69,75,86.
Studies of eIF4 following brain I/R showed that there was no change in eIF4E, but there
was degradation of eIF4G, which was greatest in the CA1 region of the hippocampus64,70. The
main finding of studies of eIF4 subunits is the calpain-mediated degradation of eIF4G following
brain I/R. It is not known at present in which cell types changes in eIF4G occur or the
significance of the changes in eIF4G. As cell death can be induced in global models without
degradation of eIF4G72,102, its degradation cannot be considered essential to DND in global
models.
C. Mechanisms of Prolonged Translation Arrest
To try to discover the cause of the persistent TA, recent work has studied mechanisms of
TA other than the regulation of translation initiation. There are two main models and both share
the common idea that translational machinery is sequestered into molecular complexes that
cannot perform protein synthesis. These models are called cotranslational aggregation and the
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ribonomic dysfunction models.
1. Cotranslational Aggregations
The first model is called cotranslational aggregation proposed by Dr. Hu’s laboratory71-72.
Extensive studies on neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s
disease, and prion-like diseases demonstrated an increase in unfolded proteins in pathological
neurons73. An improperly folded protein, like amyloid-beta peptide precursor in Alzheimer’s
disease, is ubiquinated and accumulated as protein aggregates throughout the cytoplasm73.
Ubiquination of improperly folded and non-functional proteins is a signal for transport to the
proteosome and subsequent degradation. However, since the quantity of the unfolded proteins
exceeds the rate at which they are degraded by the proteosomes, these abnormal proteins clump
together irreversibly throughout the cytoplasm.
The basis for Dr. Hu’s model of cotranslational aggregation is similar to changes seen in
chronic neurodegenerative disorders.

Studies from the Hu lab showed that two types of

ubiquinated particles accumulate in post-ischemic neurons74,71. The first particle was termed
“ubi particles” because it was cytoplasmic, relatively large (diameter ~ 1 micron) and contained
ubiquitin. Ubi-particles are visible under the light microscope, forming in all post-ischemic
neurons immediately with reperfusion. However, the ubi-particles disappear from resistant areas
by 24 hr reperfusion, but persist in the ischemic vulnerable CA1 in an altered form. The second
particle, termed protein aggregates (PAs), is visible only under the electron microscope and was
roughly 200 nm in diameter. PAs persisted in the soma and dendrites of CA1 neurons after 24 hr
reperfusion, but were absent in resistant neurons, such as the dentate gyrus. Later studies from
Dr. Hu’s lab investigated the composition of PAs75. Proteins that were shown to accumulate in
the PAs were: (1) initiation factors, such as subunits of eIF2 and eIF4, (2) protein folding
chaperones such as HSC70, and (3) proteins that make up the 40S ands 60S ribosomal subunits
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such as ribosomal protein S6. Therefore, the composition of the PAs suggested they were
involved in prolonged TA by sequestering components needed for translation. Further, that PAs
occurred only in ischemic vulnerable neurons such as CA1 was an unambiguous correlation with
the time course of persistent TA and DND, something that has not been demonstrated to this
point when only changes in initiation factors have been studied.
Based on this evidence, Dr. Hu has proposed the following model of cotranslational
aggregation for prolonged TA in post-ischemic CA1 neurons. He proposes that I/R cause
misfolding of nascent peptides during the process of translation elongation. These then: (1)
become targets for ubiquination, and (2) clump together. When the misfolded nascent peptides
clump together, they also draw the ribosomes into the aggregates of misfolded proteins, thereby
sequestering ribosomes. This process is what is meant by the term “cotranslational aggregation”.
Cotranslation aggregation provides an alternative pathway, other than eIF2α phosphorylation,
that could potentially explain why there is irreversible prolonged TA in reperfused neurons
destined to DND.
Although there is good evidence to support this model, it has two main weaknesses. The
first is quantitative. The total amount of translational components that get sequestered in the PAs
is ~ 10-15% of ribosomal components, and ~ 35% of co-translational chaperones. PAs have not
been shown to quantitatively sequester any single translational component69. A second weakness
of this model is that it does not take into account the regulatory changes in initiation factors that
were described above, namely the phosphorylation of eIF2α and the degradation of eIF4G. We
now develop our main ideas of an alternative model for prolonged TA.
2. Ribonomics
This model is the working model we use in our laboratory and is the outcome of work in
Dr. DeGracia’s lab over the past ~7 years. Unlike Dr. Hu’s model, the ribonomic dysfunction
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model takes into account the changes in translation initiation that have been identified by Dr.
DeGracia, Dr. Burda, Dr. Paschen and
other

investigators

years2,63,65,.

Before

over

the

explaining

past
the

ribonomic dysfunction model, I will first
define the term ribonomic.
The term “ribonomic” is similar to
the idea of genomic or proteomic, in that
it refers to a total complement of mRNAs
in the cell at any given instant. There is
more to this idea however. The idea is
meant to capture the fact that there are
many layers of regulation of the cellular

Figure 2. The ribonomic network.

mRNAs that begin from the point of mRNA transcription and continue to the point an mRNA is
ultimately degraded in the cytoplasm. In between, an mRNA molecule undergoes complex
patterns of localization and regulation via a large number of binding partners. Therefore, the
idea of ribonomic refers to the regulatory interactions of mRNA molecules with either proteins
or microRNAs76. Figure 2 The ribonomic network.
An important aspect of the cellular ribonome is that mRNAs undergo very specific
subcellular localization via a number of structures that have been identified to be involved in
mRNA function (Figure 2). The known structures in the nucleus are the splicesome and the
mRNA nuclear transport complex. In the cytoplasm, the structures that localize mRNAs are
stress granules (SGs), processing bodies, HuR granules, and polysomes. Each of these structures
plays a role in mRNA function. Stress granules are like a train station and route mRNAs
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amongst the other ribonomic structures77. Processing bodies are the particles that degrade
mRNAs, and in this regard are similar to what the proteosome is to proteins78. Polysomes are
now viewed as one of these mRNA control particles69, and these are where the genetic
information coded in an mRNA gets converted to protein. HuR granules are structures that are
thought to bring functionally related mRNAs together to carry out complex genetic
programs79,80. Dr. Jack Keene, one of the leaders in studying HuR granules, invented the idea of
“mRNA operons”81. Similar to bacterial operons, in which several genes with a coordinated
function are translated at the same time, the mRNA operon is the HuR granule that brings
together functionally related mRNAs so that they may be acted upon at the same time in
eukaryotic cells. This action may involve coordinated translation, coordinated silencing (e.g. the
mRNAs are present but not translated), or coordinated degradation (by routing the groups of
mRNAs to processing bodies for degradation).
VII. The Ribonomic Model and Brain I/R
The ideas surrounding the concept of ribonomic regulation of mRNA offers new insights
into possible mechanisms of persistent TA following brain I/R. Since the seminal work of
Kleihaus and Hossmann54 the field has been focused on changes in ribosomes as the cause of
TA. However, mRNA is just as important to protein synthesis as ribosomes are, and there has
been a relative neglect in the field at understanding changes in mRNA and its regulation, and its
possible role in TA.
There are many, many studies in the field looking at the changes in specific mRNAs
following I/R, either by in situ hybridization or PCR. But there are only two papers that looked
at global changes in mRNAs following I/R. Maruno & Yanagihara82 showed a decrease in total
mRNA in reperfused CA1 compared to other brain regions. A decrease in mRNA would
contribute to TA. Matsumoto et al83, showed, using gradient centrifugation, that there was a
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change in the subcellular fractionation of mRNAs in vulnerable neurons following ischemia83.
The interesting point here is that, if there are indeed major changes in mRNA following brain
I/R, such as could be envisioned looking at the ribonomic network, then this brings into question
the interpretations of all of the many studies that have evaluated individual mRNAs. To date,
there has only four studies that looked at the ribonomic network, and these have all been carried
out in Dr. DeGracia’s lab101-102. I will now review these studies.
A. SGs in Reperfused Neurons
In 2005, Kayali et al. evaluated SGs in rat hippocampal formation using the cardiac arrest
and resuscitation model of global brain ischemia101.

SGs are known to form following

phosphorylation of eIF2α when cells undergo stress77. SGs have been shown to function to
move mRNAs around the cell into other ribonomic structures where the most focus to date has
been the movement of mRNAs from polysomes to processing bodies84.

Since eIF2α

phosphorylation was a well established change in reperfused neurons65, Kayali et al
hypothesized that there might be a difference in SGs between resistant (e.g. CA3) and vulnerable
(CA1) post-ischemic neurons. This hypothesis linked to what was already a well-established fact
of reperfused neurons, unlike Dr. Hu’s model of cotranslational aggregation.
A 10-minute global brain ischemia was induced by cardiac arrest followed by reperfusion
durations of 10 min, 90 min, or 4 hours. Double-labeling immunofluorescence (IF) for two SG
components, S6 and TIA-1, was used for evaluation. SGs in resistant regions, such as CA3,
hilus, and dentate gyrus (DG) increased at 10 min reperfusion and returned to control levels by 4
hr reperfusion (4hR), however, this was not the case in vulnerable CA1. At 4hR, S6 was solely
localized within SGs only in CA1 pyramidal neurons. This study led to the conclusion that
prolonged TA in reperfused CA1 pyramidal neurons was due to loss of the 40S ribosomal
subunits and the complete sequestration of the remaining 40S ribosomal subunits in SGs at a
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time when eIF2(P) has dephosphorylated substantially85. This conclusion related SGs and the
persistent TA in CA1 to the acute phase of TA mediated by eIF2α phosphorylation86. It also
provided a mechanism of the continued inhibition of protein synthesis in reperfused CA1
pyramidal neurons after eIF2α had been dephosphorylated.
B. Problems with the SG Mechanism
The main limitation of the Kayali et al study was that it looked only to 4 hr reperfusion,
which is well before the time of DND at ~ 72 hr reperfusion101. This was a technical limitation
due to the difficulty of keeping rats alive for longer durations following cardiac arrest and
resuscitation. Following cardiac arrest, rats experience severe peripheral organ damage, which
was studied by Dr. Montie87-88. Because of these limitations the cardiac arrest model was
unsuitable for studying longer reperfusion durations to assess the role of SGs in neuronal death.
The experiment was repeated with a different model of global ischemia, the bilateral
carotid artery occlusion plus hypovolemic hypotension model (2VO/HT) of Smith et al89. This
model does not cause peripheral organ damage, so animals can be reperfused for any duration.
When 10 min of ischemia was applied with the 2VO/HT model, although CA1 death occurred at
72 hr reperfusion, there was no loss of S6 or sequestration of S6 in SGs at 4 hr reperfusion69.
That S6 sequestration in SGs did not occur at 4 hr following 2VO/HT indicated that the SG
mechanism of prolonged TA was not general. In the 2VO/HT model, the number of SGs
increases similarly in both CA1 and CA3: there was a transient increase at 10 min reperfusion
which returned to control levels for the remainder of reperfusion69.
In the 2VO/HT model, DeGracia et al90 showed that SGs eventually fuse with protein
aggregates, showing that Dr. Hu’s model and Dr. DeGracia’s model were not only compatible,
but that the mechanisms converged. However, even in this case, there was not a wholesale
sequestration of any tested ribosome component in the SG/PA hybrid particles.
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Dr. Hu performed a study of protein aggregates following stroke75, and in this study
stained brain slices for ribosomal protein S6. He showed a loss of S6 staining similar to that
observed in the cardiac arrest model in the Kayali et al study101. However, SGs were not
evaluated in this study. It is of interest to note the loss of S6 staining in the Liu et al study
because below, in our results with Long Evans rats, we show that of the 14 antigens stained for
following focal ischemia, all 14 showed loss of staining in the core region.
C. mRNA Granules
In a second ribonomic-oriented study using the cardiac arrest model, DeGracia et al

91

,

immuno-mapped eIF4G following global brain I/R. Here it was observed that in the cytoplasm
of reperfused neurons, the eIF4G staining took the form of granular “clumps”. This paper
suggested that the eIF4G “clumps” might represent degradation products of eIF4G, or possibly
that eIF4G had been sequestered in the form of the ubi-protein complexes identified by Dr. Hu’s
laboratory.
In recent work from our lab, in which I participated, we used fluorescent in situ
hybridization (FISH) to visualize poly-adenylated mRNAs (pA) in reperfused neurons using a
poly(T) probe102. We also performed colocalization studies of pA with a number of antigens by
double staining with pA FISH and immunofluorescent histochemistry (IF).
Figure 3 Figure 3shows the main result of this study. We observed the pA staining in
non-ischemic controls (NIC) as diffuse in the cytoplasm. However, with reperfusion, the pA
also took the form of granular “clumps” in the cytoplasm, very similar to what was observed
with eIF4G in the DeGracia et al (2006)91 study. The granulated form of mRNA in the cell
cytoplasm we termed “mRNA granules”.
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Figure 3 : Detection of mRNA
granules by pA FISH and co-IF
for 40S, 60S and PABP.
Left, non-ischemic controls (NIC)
where the pA and proteins had a
“smooth”
and
relatively
homogeneous staining pattern in
the cell cytoplasm. Right:
following 10 min global brain
ischemia and 1 hr reperfusion, the
pA staining patterned formed
granular structures, the mRNA
granules. The mRNA granules did
not colocalize with markers of the
40S and 60S ribosomal subunits,
but did colocalize with pAbinding protein (PABP). Images
adapted from 102.

In the Jamison et al (2008)102 study, the mRNA granules colocalized with eIF4G
indicating that the eIF4G granulation reported in the DeGracia et al., (2006)91 study were not
degradation products, but were eIF4G localized in the mRNA granules. The mRNA granules did
not colocalize with TIA-1, proving they were not SGs. They did not colocalize with TTP, a
marker of processing bodies92, proving they were not processing bodies. The mRNA granules
did colocalize with HuR, and we therefore believe that the mRNA granules are the HuR granules
discussed above, which have been described and studied by the Keene Laboratory.
Most significantly, as shown in Figure 3, when double labeling for pA and S6, a marker
of the 40S ribosomal subunit, or pA and ribosome P antigen, a marker of the 60S subunit93, was
performed, the mRNA granules did not colocalize with either antigen. That is, the mRNA
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granules did not colocalize with either the 40S or 60S ribosomal subunits. On the other hand, as
shown in Figure 3, in non-ischemic controls, pA/S6 and pA/RPA strongly colocalized in the
form of a diffuse cytoplasmic staining. The Jamison et al102 study also evaluated in vivo
translation after administration of radioactive amino acids. The result was obtained that every
reperfusion time point in which neurons showed the presence of the mRNA granules also
showed inhibition of in vivo protein synthesis. Therefore, we now believe that the mRNA
granules sequester mRNAs away from ribosomes, and that this provides a second mechanism, in
addition to the cotranslational aggregation model of Dr. Hu, of prolonged TA in reperfused CA1
neurons.
In fact, on the basis of the pA staining patterns presented in the Jamison et al study, it
appears that the pA signal is quantitatively present in the mRNA granules. This then is the first
observation of any change in a translational component that: (1) correlates precisely with the full
time course of TA, and (2) represents a quantitative transformation that would mechanistically
explain the prolonged TA during reperfusion.
VIII. Summary and Hypothesis
To summarize the main points of the background, above it was discussed how a
prolonged TA correlates exactly with the DND of neurons following both focal and global brain
ischemia. Many different mechanisms of prolonged TA have been tested. Changes in ribosome
regulation occur mostly at the early reperfusion time points and do not explain the prolongation
of TA. Some percent of ribosome components get sequestered in PAs, which can contribute to
prolonged TA, but cannot fully explain it. To date, the only observation of changes in the
translational system that is both apparently quantitative and correlates precisely with the time
course of TA is the observation of mRNA granules following global brain I/R. It is currently
unknown if a similar sequestration of mRNA away from ribosomes occurs following focal brain
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I/R, leading therefore to the main hypothesis of my Dissertation:
Hypothesis 1 : Focal brain ischemia causes sequestration of mRNA away from
ribosomal subunits.
Above it was also discussed how diabetes worsens outcome following brain I/R. To the
best of my knowledge, and after a thorough literature review, the translation system in the
reperfused brain of diabetics has not been studied. Since TA correlates precisely with cell death,
and cell death is increased in diabetics, I therefore offer the second main hypothesis of my
dissertation:
Hypothesis 2 : Diabetes worsens the TA associated with focal ischemia to increase
the amount of cell death.
IX. Factors Affecting Experimental Designs
The above hypotheses will be tested by the following experimental strategies.
1) Determine the formation of mRNA granules in the focal ischemic brain, with and
without diabetes.
2) Correlate the extent of mRNA granule formation with the extent of brain cell death in
the focal ischemic brain.
The methods utilized to carry out these experimental strategies included (1) an animal
model of focal brain ischemia based on MCAO, (2) an animal model of diabetes using
streptozocin (STZ)-induced destruction of pancreatic beta cells, (3) the use of standard staining
methods to determine the extent of necrotic infarcts by the lack of brain slice staining with the
compound 2,3,5 triphenyltetrazolium chloride (TTC), and (4) detection of pA mRNAs via
fluorescent in situ hybridization, and a determination of their colocalization with a variety of
protein antigens via immunofluorescent histochemistry.

Before proceeding to Methods and

Results, some further rationalization of the Experimental Designs is in order.
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A. Transient or Permanent Focal Brain Ischemia.
Below we describe the use of the MCAO model of focal brain ischemia. Unlike the
global ischemia models used routinely in the lab, MCAO results in an incomplete ischemia,
meaning that cerebral blood flow is never reduced to zero. Even during the ischemic period in
which the filament blocks the MCA, the remainder of the brain blood flow is normal and
intrinsic brain and vascular reflexes are activated to enhance blood flow to the MCA territory via
collateral anastomoses, creating a complex and only partially understood blood flow gradient124.
Thus, blood flow in the occluded territory during the ischemic period of MCAO can range from
between 20-50% normal117, which itself is animal strain dependent (see below).
In contrast, with models of global brain ischemia, there is a discreet and well-defined
period of zero blood flow (the ischemic period) followed by discreet periods of reperfusion.
Also, the onset of ischemia and subsequent onset of reperfusion are often rapid. Thus, the
ischemic insult with global models can be thought of as a square wave. But a similar logic does
not hold for the MCAO focal model.
These considerations are important with respect to the translational system as follows. In
global models, where blood flow is zero during ischemia, intracerebral ATP levels also go to
zero, and ATP dependent processes come to a halt. The phosphorylation of the alpha subunit of
eIF2 requires ATP as a substrate.

Thus, in global models of brain ischemia there is no

phosphorylation of eIF2 during the ischemia period64; this phosphorylation event occurs within
the first minutes of reperfusion after ATP levels have increased enough to allow it to proceed.
On the other hand, in a study by Wulf Paschen’s lab, the levels of eIF2(P) were observed to be
at their maximum at the end of a 2 hr period of MCAO2. During the subsequent reperfusion
period the levels of eIF2(P) decreased from this maximum and returned to pre-ischemic
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(control) levels by 6 hr reperfusion. Thus, the focal case is much different from the global case
with respect to the phosphorylation of eIF2, which is a key event in the regulation of translation
in neurons following I/R.
Therefore, the logic of our study design is different from a typical study using a global
ischemia model that would use a fixed time of ischemia (usually 10 min) followed by a time
course of reperfusion. Because the “ischemic” period in an MCAO model is actually a complex
mix of ischemia and reperfusion occurring in the same brain, the main focus of the studies we
shall describe involve what is (perhaps not so accurately) called “permanent” focal ischemia, in
which we will evaluate increasing durations of MCAO. We feel this is a necessary set of studies
to perform before any attempt to perform a fixed value of ischemia followed by increasing
durations of reperfusion, or what is commonly referred to as “transient” MCAO. The use of
transient MCAO for the major studies reported here (e.g. those involving the Long Evans rat
strain described in Chapter 3) was used primarily to validate the model by demonstrating
production of a necrotic infarct.
B. Rat Strain Effects following MCAO
There is a substantial literature showing differences in outcome amongst different strains
of rodents, specifically with the MCAO model94. For example, a study by Prieto et al (2005)117
showed statistically significant differences in cerebral blood flow during the MCA occlusion
period in different rat strains. In this study, Wistar showed the highest blood flows (average ~
50%), Sprague Dawley was intermediate (average ~ 38%), and Long Evans showed the lowest
blood flows (average ~ 28%). Why different strains demonstrate different blood flows is not a
topic we study here. But it is a factor we attempt to account for by performing our studies on
two different rat strains: Wistar and Long Evans. By using the Wistar strain, we can compare
our results to previous studies of the effect of diabetes after MCAO95,96,104. By using the Long
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Evans strain, we can compare our results to the reported studies of the translation system and the
mRNA granulation process in post-ischemic brain64-65,90,101-102.
C. Effect of Anesthetic on Outcome from MCAO
The effect of anesthetic on outcome following brain I/R is a highly researched area.
Hundreds of published studies have reported that anesthetics can affect outcome either to the
positive or negative. It is interesting to note, however, that, as with every other agent that has
shown laboratory neuroprotection, the ostensible neuroprotective properties of anesthetics has no
bearing at all on clinical anesthesia in a practical clinical setting97. The common inhalation
anesthetic halothane was used for the majority of studies reported here. However, in my initial
work with the Wistar strain, some experimental groups were performed using the also common
combination of the dissociative anesthetic ketamine and the muscular relaxant xylazine. I report
these results below even though no significant differences were observed.
X. Overview of Experimental Plan
Given the above considerations, the overall experimental plan is illustrated in Figure 4.
The general plan was that experimental groups were performed, from which tissue slices were
made and then stained to detect either the infarct (TTC) or molecular markers. Specific designs
and analytic methods are reported in subsequent chapters. The different experimental groups are
illustrated schematically in Figure 4 and broken out into three categories: (1) animals strain
(Wistar vs. Long Evans), (2) type of focal ischemia (transient vs. permanent), and anesthetic
used (ketamine/xylazine (K/X) vs. halothane). The main experimental groups, all of which used
halothane anesthetic are listed in Table 1. The following chapters describe the Methods and
Results as follows: Chapter 2 describes the Wistar strain studies; Chapter 3 describes studies
with untreated Long Evans rats, and Chapter 4 describes the studies with diabetic Long Evans
rats. Chapter 5 will then discuss the integrated results.
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Focal brain ischemia
•
•
•

Perfusion fix/tissue slices

Wistar vs. Long Evans
Permanent vs. transient MCAO
ketamine/xylazine vs. halothane

Stain tissue
•
•

Analyze results

TTC
pA FISH – mRNA granules
–
–

map 3D distribution
co-stain with 14 protein antigens

Figure 4: Overview of Experimental Designs
Table 1: Experimental Groups Overview, including number of animals per group (n).
Strain
Ischemia
Reperfusion
Group name
Wistar
2 hr
2I
(n = 3/grp)
2 hr
4 hr
2I/4R
2 hr
24 hr
2I/24R
2 hr
7 days
2I/7dR
Long Evans
(n = 5/grp)

2hr
2hr
4 hr
6hr
8hr

24 hr
-

2I
2I/24R
4I
6I
8I

Long Evans
Diabetic
(n = 4/grp)

0.5 hr
1hr
4 hr
6hr

-

0.5I
1I
4I
6I
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CHAPTER TWO: Studies on Wistar Strain - Methods and Results
I. Rationale
Since my 2nd major hypothesis sought to evaluate the effect of diabetes on the translation
components, I began my work by evaluating the Wistar rat strain so I could compare to previous
studies of diabetes and focal brain ischemia95,96,104. Specifically, the 2005 study of Rizk, Rafols
and Dunbar104 provided the starting point for my investigations. This study showed that 2 hr
transient MCAO plus 24 hr reperfusion did not generate an infarct in non-diabetics but that
diabetic animals showed a large infarct at this same end point, and that neurons of the diabetic
brains showed substantial activation of apoptotic pathways before the application of MCAO. I
therefore sought to evaluate the same time course of MCAO with and without diabetes. The
intent of the studies described in this Chapter was to first establish a baseline of mRNA granule
formation along a time course of transient MCAO in non-diabetic Wistar rats, and then repeat the
studies using diabetic animals.
To briefly summarize the results of the studies in Wistar rats, I was unable to detect
mRNA granules at any time point of reperfusion, out to 7 days. Instead, I observed only a very
minor formation of mRNA granules at the 2 hr ischemia-only time point. We considered that the
negative result may have been due to two factors. First, it may be been an anesthetic effect.
Second, we considered that at 2 hr MCAO, the small number of mRNA granules detected
reflected either the beginning or end of a time course, and that more mRNA granules might be
identifiable at either earlier or later ischemia durations. I therefore conducted a series of studies,
shifting from halothane to K/X, and also evaluating various durations of ischemia. The results of
these studies were also essentially negative.

Although mRNA granules were sporadically

detected in the 2 hr MCAO + K/X group, their frequency was not apparently different from the
halothane group. In general, the frequency of mRNA granules was much lower than would have
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been expected from our experience with the global brain ischemia model102.
Being unable to establish a baseline of mRNA granule formation, studies of diabetes in
the Wistar strain were not conducted. It is for these reasons I turned to the Long Evans strain
and those studies are described in Chapters 3 and 4. Here I report my observations of low
frequency mRNA granule formation in the Wistar strain neurons. Because the frequency of
mRNA granule formation was so low in the Wistar strain, there is not a comprehensive analysis
such as described for the Long Evans strain in Chapter 3. Additionally, because of the link
between TA and stress responses, I stained to determine if the Wistar rats translated HSP70
protein during the reperfusion time course.
II. Materials
HuR primary antiserum was purchased from Santa Cruz Biotechnology, Inc (Santa Cruz,
CA). Rabbit polyclonal anti-PABP was purchased from Abcam (Cambridge, MA). Mouse
monoclonal ribosomal protein S6 was purchased from Cell Signaling (Danvers, MA). HSP70
antiserum was from Stressgen (Ann Arbor, MI). Alexa FluorR 488 donkey anti-goat IgG, Alexa
FluorR 555 donkey anti-rabit IgG and Alexa FluorR 555 anti-mouse IgG, used for IF
histochemistry were purchased from Molecular Probes (Eugen, OR). A 5’ biotinylated 50-mer
oligo-dT probe used for FISH was made by Integrated DNA Technologies, Inc. (Coralville, IA).
Prehybridization and hybridization buffers were obtained from the mRNA locator In Situ
Hybridization Kit (Ambion, Austin, TX). TTC was purchased from Sigma-Aldrich (St. Louis,
MO).
III. Methods
A. Animal Model
All animal experiments were approved by the Wayne State University Animal
Investigation Committee and were conducted following the Guide for the Care and Use of
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Laboratory Animals (National Research Council, revised 1996). Every effort was made to
minimize animal suffering and the total number of animals used. Unilateral focal brain ischemia
was induced in male Wistar rats (weight 275-300g; Harlan, Indianapolis, IN) using the MCAO
intraluminal suture model of Hatashita et al98. The experimental groups, anesthetic, and number
of animals per group is shown in Table 2:
Table 2: Experimental groups and anesthetic for studies of Wistar rat strain.
Experimental group
anesthetic
n
Ischemia duration
Reperfusion duration
2I
halothane
3
2 hr
0
2I/4R
halothane
3
2 hr
4 hr
2I/24R
halothane
3
2 hr
24 hr
2I/7dR
halothane
3
2 hr
7 days
0.5I
K/X
3
½ hr
0
1I
K/X
3
1 hr
0
1.5I
K/X
3
1 ½ hr
0
2I
K/X
3
2 hr
0
4I
K/X
3
4 hr
0
Anesthesia was initiated with either a single intraperitoneal (IP) injection of 0.25 ml/kg
and 0.8 ml/kg K/X or 5 % halothane and maintained with 1.5 % halothane via facemask for the
duration of the surgery. Animals were supine and core body temperature was maintained at 37 ±
0.5˚ C by a homeostatic blanket system (Harvard Apparatus) using a rectal thermometer. Rats
were maintained normothermic during the entire surgery period. After shaving the cervical
region and cleansing the area with betadine, a midline cervical incision was made in order to
expose the omohyoid and sternomastoid muscles, which were separated using a retractor to
expose the right common (CCA) and its bifurcation. The right CCA was dissected free of
surrounding tissue and nerves. All branches of the external carotid artery (ECA) were isolated
and coagulated. The CCA was clamped using a vascular clip and the internal carotid artery
(ICA) was isolated and also clamped. Under an operating scope, a small cut was made in the
ECA and a nylon filament ~ 18.5 mm in length was inserted into the CCA and secured. The
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vascular clip was then removed from the ICA and the stump of the ECA was transected in order
to facilitate maneuvering of the nylon filament into the ICA. The filament was carefully passed
up into the lumen of the ICA, blocking the MCA at its origin. Laser Doppler flowmetry (LDF)
from the ipsilateral cortex, at a coronal level approximately 1 mm anterior to Bregma was used
to confirm a reduction in blood flow. Once the LDF readings stabilized, the vascular clip was
removed from the CCA and all incisions were closed. Rats were then returned to their cages and
allowed to recover. Upon regaining consciousness, rats displayed paresis of the left forelimb and
unilateral circling.
B. 2,3,5 Triphenyltetrazolium Chloride Staining
Immersion staining of TTC was used to measure tissue viability and evaluate infarct size.
The principle of TTC staining relies on the oxidation of the tetrazolium salt by intact
mitochondrial dehydrogenase into a red, lipid-soluble formazan, which yields the carmin red
product, formazan99. Viable tissue therefore stains deep red, whereas infarcted (necrotic) tissues
lack dehydrogenase activity and therefore do not stain. Thus, the infarcted area (white) can be
easily distinguished from the surrounding intact tissues99-100. At the appropriate times, the rats
were decapitated, the brains rapidly removed, and placed in ice cold 0.9% NaCl for 5 minutes.
The brains were then sectioned into 2 mm thick coronal sections using a brain matrix and then
placed in a 2% solution of TTC in 0.9% NaCl, covered and allowed to incubate for 30 minutes at
37 ˚C on a shaker. At the end of the incubation period, the sections were removed and placed in
4% paraformaldehyde (PFA) at 4˚C for post-fixing. Digital images of the brain sections were
taken 48 hours later.
C. Double-labeling Immunofluorescence and Fluorescent In Situ Hybridization
At the end of the permanent ischemia or reperfusion periods, the animals were reanesthetized and transcardially perfused with 50 ml of 0.9% sodium chloride followed by 250 ml
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of 4% PFA in 0.1M PBS at a flow rate of 20 ml/min. The brains were removed and post-fixed
overnight in the PFA solution at 4˚C. Using a vibratome, 50 micron slices through the anterior
forebrain were obtained and stored at -20˚C in cryostat solution until used.
IF histochemistry for HSP70 was performed as follows. Brain slices were washed in
0.1M PBS for 10 minutes x4 then blocked in 10% normal donkey serum (NDS) in 0.1M PBS
containing 0.3% Triton X-100 (PBS-TX) solution for 25 minutes, following by washing x3 for
10 min in 0.1M PBS. Slices were then immersed in primary antibodies in 1% NDS in PBS-TX
at room temperature on a shaker overnight. The following day, slices were washed x3 for 10
min in 0.1M PBS and then incubated in secondary antibody solution, in the dark, for 2 hours and
washed again x3 for 10 min in 0.1M PBS.101 HSP70 antiserum was used at a 1:200 dilution.
Double IF/FISH was performed exactly as described previously102 with poly-T probe at
50 ng/ml and the following primary antisera dilutions: 1:25, anti-HuR; 1:250, anti-PABP; 1:25,
anti-S6. Secondary antisera dilutions in 1% NDS in PBS-TX were: 1:300, Alexa 488; 1:300,
Alexa 555.
Briefly, Double IF/FISH was performed in a two stage procedure in which the FISH
procedure was a modification of that described in Bessert and Skoff (1999)103. The first stage IF
procedure was as described above. The second FISH stage was performed under low light
illumination or in the dark. At the end of the IF procedure slices were mounted on lysine-coated
slides. IF-stained sections were fixed in 3.6 % formaldehyde in PBS for 10 min at room
temperature and then drained and blotted. Prehybridization was carried out in a box humidified
with 50% formamide/4X SSC inside an incubator at 32oC for 3 hr in prehybridization buffer
(mRNAlocator In Situ Hybridization Kit, Ambion, Austin, TX).

Slides were then incubated

overnight in the same apparatus in a solution of 50 ng/ml of a 5’-biotinylated 50-mer oligo-dT
probe (Integrated DNA Technologies, Inc., Coralville, IA), dissolved in hybridization buffer
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(mRNA Locator In Situ Hybridization Kit).

The next day, all subsequent processing was

performed at room temperature. Slides were washed x2 in 2X SSC for 10 min and then
incubated in 1:500 Alexa 488-labeled streptavidin (S32354, Invitrogen, Carlsbad, California) in
4X SSC/0.1% Triton X-100 for 60 min. Slides were then washed once in 4X SSC for 10 min
followed by incubation in 2X SSC/0.1% Triton X-100 containing 1: 667 of biotinylated goat
anti- streptavidin (BA-0500, Vector Laboratories, Burlingame, CA) for 60 min. Slides were
again washed once in 4X SSC for 10 min and then incubated in 1:667 Alexa 488-labeled
streptavidin in 2X SSC/0.1% Triton X-100 for 60 min. Slides were then washed sequentially in
4X SSC for 10 min and 2X SSC for 10 min, and then coverslipped for viewing.
Slides were examined on an Axioplan 2 Imaging System (Carl Zeiss, Oberkochen,
Germany) equipped with an ApoTome. Excitation at 488 nm and 568 nm, and emission at 518
nm and 600 nm were used for Alexa 488 (green) and Alexa 555 (red), respectively. Optical
sectioning was performed using the X63 oil immersion objective to generate z-stacks as
previously described101.

Fluorescent micrographs shown in the figures are orthographic

projections of 2.45 micron z-stacks (7 x 0.35 micron optical sections), unless otherwise stated.
Validation of antisera staining was previously described101-102.
IV Results
A. TTC staining
As a means to validate the MCAO model and evaluate infarct volume, TTC staining was
performed on male Wistar rats that underwent 2 hours of MCAO followed by 4 hours, 24 hours
and 7 days of reperfusion. 2 hours of MCAO did not lead to an appreciable necrotic core, at any
reperfusion duration, even to 7 days reperfusion (Figure 5). This finding was consistent with
previous studies conducted in this strain where no visible infarct was seen with TTC staining,
following 2 hours of ischemia and 24 hours of reperfusion104.
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Figure 5: TTC staining of Wistar rat strain
following transient focal ischemia.
Male Wistar rats were subjected to
normothermic, unilateral MCAO for 2 hours
of ischemia only (2I), 2 hours of MCA
ischemia plus: 4 hours of reperfusion (4hR),
24 hours of reperfusion (24hR) and 7 days
of reperfusion (7dR). Representative 2 mm
slices arranged anterior (top) to posterior
(bottom), encompassing the MCAO
territory which includes the striatum.

B. Frequency of mRNA granule formation
Microscopic studies conducted to investigate whether or not mRNA granule formation
took place following MCAO in the Wistar rat revealed that mRNA granules formed only at a low
frequency. Granulation of mRNA was detected in only 2 of the 15 animals tested with K/X and
2 of the 12 animals tested using halothane (Table 3). Significantly, for both anesthetics, the only
experimental group showing mRNA granules was the 2 hr MCAO ischemia group. mRNA
granules were not detected in any reperfused samples. The use of the injectable anesthetics
ketamine and xylazine or the inhalational anesthetic halothane had no effect the outcome
remained the same. With respect to the experimental groups, therefore, the frequency of mRNA
granule formation was 67% for both the K/X and halothane 2 hr MCAO groups, and zero for all
other groups. Wistar rats, in general, have been shown to be more resistant to ischemic insults
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when compared to other strains with comparable physical and physiologic parameters105,106. The
lack of mRNA granule formation in this instance, consistent with the TTC staining result,
indicates the Wistar strain did not experience a severe enough ischemic insult to induce mRNA
granulation.
Table 3: Frequency of mRNA granule formation in the Wistar rat following MCAO.
Anesthetic
total n
n with mRNA granules
K/X
15
2 (13.3 %)
halothane
12
2 (16.7 %)
Animals were tested using either ketamine/xylazine (K/X) or halothane anesthesia.
Error! Not a valid bookmark self-reference. Figure 6: Distribution of mRNA granule containing neurons in Wistar rats at 2 hr MCAO.

C. Histological assessment of mRNA granules in Wistar rats
In spite of their low frequency of occurrence, I assessed the mRNA granules in the 2I
Wistar rat group to determine if their colocalization
properties were similar to that observed following global
brain ischemia.

In the four samples displaying neurons

containing mRNA granules, these neurons were sparsely
scattered in clustered areas on the ipsilateral hemisphere as
shown in Figure 6. A crude estimate would put their area
to be less than 5% of the total hemispheric area, and they
tended to be more medially located in the ipsilateral
hemisphere.
Figure

7,

panels

A,

B

and

C,

show

photomicrographs of mRNA-granule containing neurons

Figure 6 : A rough indication of the
distribution
of
mRNA-granule
containing neurons in Wistar rats at
2hr MCAO. Green circles indicate
scattered areas where the neurons
showed mRNA granulation. The dark
red area is where a necrotic core
would be expected based on the MCA
territory, and the surrounding light red
area represents where penumbra is
expected.

co-stained with pA FISH and IF for S6, PABP and HuR, respectively. For each co-staining pair,
sham operated non-ischemic control (NIC) animals are shown along with the 2I samples. The
first column is the merged image, the second column the pA channel (green) and the third
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column is the respective red channel for the protein antigen.
Figure 7A shows pA/S6 staining in layer II cerebral cortical neurons. The NIC samples
showed a smooth and homogeneous pattern of pA/S6 colocalization in the cell cytoplasm. This
colocalization likely represents normal mRNA-ribosomal association during the protein
translational process. Neurons in the ipsilateral region of the 2I sample formed mRNA granules
that did not colocalize with S6, which is better visualized by observing the separate channels. In
the pA channel there is concentration of the pA signal that is not present in the S6 channel.
Compared to the results of layer II cortical staining I will show in Chapter 3, the amount of
mRNA granulation in Figure 7A can be considered only partial.
A more obvious mRNA granulation was apparent in the layer V pyramidal neurons seen
co-stained with PABP in Figure 7B and HuR in Figure 7C. For pA/PABP, it is again seen how
the NIC showed a diffuse cytoplasmic colocalization. For the 2I sample, both the pA and PABP
signal show granulation, which colocalize to form yellow mRNA granules in the merged image.
For pA/HuR (Figure 7C), the mRNA granules were quite obvious compared to NIC samples.
Although the merged image of pA/HuR does not produce yellow mRNA granules, it can be seen
that HuR is indeed granulated in the HuR channel of the ischemic but not NIC sample.
In the Jamison et al (2008) study of mRNA granules in global ischemia, identical patterns
were seen in which S6 did not, but PABP and HuR did colocalize with the mRNA granules.
Therefore, in spite of the relatively infrequent occurrence of mRNA granules in the Wistar rat
strain following focal I/R, the mRNA granules are similar to those discovered following global
ischemia with regard to colocalization with these three antigens.
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Figure 7 : Colocalization studies of mRNA granules with S6, PABP & HuR in 2hr MCAO
Wistar rats.
(A) pA/S6 in layer II of cerebral cortex, (B) pA/PABP in layer V or cererbral cortex, (C)
pA/HuR in layer V of cerebral cortex. Merged images, pA green channel and protein antigen red
channels as indicated. Scale bars apply to each respective row.
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D. “Intermediate” pA phenotypes of some layer V neurons
As seen in Figure 7C, the layer V neurons showed distinctly identifiable mRNA granules
in the 2I samples. However we occasionally observed a phenotype that appeared “intermediate”
between fully granulated mRNA as seen in Figure 7C and the relatively smoother pA signal in
the cytoplasm of NICs. The rarity of these “intermediate” neurons made systematic study of
them

implausible

ipsilateral

and

I

LV

simply
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record

their

occurrence
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here.
Figure 8 illustrates two of these layer V pyramidal neurons each of which displayed a
prominent ridge-like pA staining pattern, which was not present in the S6 channel. The “ridges”
appeared as either perinuclear or as tracks that appeared to run along the plasma membrane and
apical dendrite.
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For the neuron in the first column of Figure 8, a “deep stack” of 37 optical sections with a
z-depth of 13 microns was acquired. This z-stack was volumetrically rendered using a method
called linear weighted averaging (LWA) to better visualize the pA staining pattern of the cell.
LWA is a non-transparent method of superimposing the optical sections that allows 3D
structures such as the ridge-like structures along the nucleus (arrow labeled 1) and plasmalemma
of the apical dendrite (arrows labeled 2) to be more readily seen. Additionally, a reticulated
structure (arrow labeled 3) was prominently visible; at this same location in the cell there was no
staining at all for ribosomal protein S6 (arrow labeled 4). Again, the relative rarity of these
prevented any type of systematic study. In Chapter 3, where systematic colocalization studies
are performed with the mRNA granules, I found these did not colocalize with markers of the
endoplasmic reticulum, Golgi apparatus, microtubules or intermediate filaments, and it is possible
the ridge-like structures identified here would also not colocalize with these structures.
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Figure 8: Layer V neurons with an “intermediate” pA phenotype in Wistar rats.
First and second columns show single layer V neurons containing “ridge-like” pA structures that
are not present in the S6 channel. Third column shows a 3D reconstruction of the neuron in the
first column using linear weighted averaging volume rendering that enhanced the visibility of the
pA structures.
E. HSP70 immunostaining
The heat shock response is a well-documented stress response that occurs in cells
following perturbations in its environment. HSP70 protein belongs to the family of heat shock
proteins that are upregulated when a cell is stressed. Previous studies have shown that hsp70
mRNA and HSP70 protein are upregulated primarily in endothelial cells of large blood vessels
following MCAO ischemia107 and that the upregulation of its translation correlates with the
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colocalization of HuR with mRNA granules102. Additionally, translation of HSP70 has been
shown to be a protective response following brain I/R108. Given that Wistar rats did not form an
infarct at any time point tested (Figure 5), I assessed the expression of HSP70 protein in order to
see if there was a correlation with the TTC staining results.
Following 2 hours of ischemia, HSP70 was expressed in different structures as a function
of reperfusion duration (Figure 9). At 4hR, only contractile cells wrapped around the surface of
endothelial cells known as pericytes stained for HSP70 in the penumbral cortex and striatum.
The morphology of the pericytes was visualized by 3D reconstruction of z-stacks of HSP70
staining (Figure 9D). At 24hR, striatal neurons prominently stained for HSP70. At 7dR only
endothelial cells of blood vessels throughout the ipsilateral hemisphere stained for HSP70.
These results show that a complex pattern of HSP70 expression occurred in the brains of the
Wistar rats following transient MCAO. The successful translation of HSP70 protein is consistent
with the lack of an infarct in the Wistar strain following MCAO.

A. 4hR, 10X

B. 4hR, 63X

200 m

C. 24hR

50 m

D. 7dR

200 m

200 m

Figure 9 : HSP70 protein
expression in different cell
types as a function of
reperfusion duration.
2 hours of MCAO ischemia
followed by: (A) 4 hours
reperfusion
(4hR)
only
showed HSP70 expression in
pericytes.
(B)
High
magnification,
3D
reconstruction of HSP70
reveals the characteristic
morphology of pericytes.
(C) At 24hR, penumbral
neurons stained for HSP70
and (D) at 7dR endothelial
staining of HSP70 occurred in
blood vessels.
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CHAPTER THREE: Studies on Long Evans - Methods and Results
I. Rationale
Although the Wistar rat strain evidenced neurons containing mRNA granules following 2
hr MCAO, and these had characteristics in common with those identified in neurons following
global brain ischemia102, their frequency of occurrence in both the experimental groups and in
terms of the area of brain tissue affected was far too small to use as a baseline for studies of the
effect of diabetes on the translational system following focal brain ischemia. Since mRNA
granules had been initially discovered in the Long Evans rat strain102, I undertook MCAO studies
in the Long Evans rat strain.
This turned out to be a fortuitous decision because the Long Evans rat strain displayed
abundant mRNA granulation of neurons in response to focal brain ischemia as I will describe in
this chapter. Because the Long Evans gave a positive result with respect to mRNA granule
formation, I undertook a systematic analysis of their distribution along a time course of ischemia
duration. A reperfusion time course was not studied here because it was first necessary to study
the degree to which mRNA granules formed at different durations of ischemia. To characterize
the mRNA granules along a time course of ischemia, three main types of analysis were
performed: (1) a study of different histological regions in the MCAO brain, (2) a three
dimensional (3D) study along the rostral-caudal extent of the brain, and (3) a comprehensive
colocalization analysis of the mRNA granules with two categories of markers: (a) mRNA
interacting proteins, and (b) markers of subcellular organelles.
II. Materials
Table 4 lists the antisera, what they are markers of, vendors and dilutions used in the
present study. All other antibodies were purchased from companies previously described in
Chapter 2. I will briefly describe each marker in the Results section ahead.
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Table 4: Antisera used for colocalization studies.
Antisera
-tubulin
APRIL
COX IV
GM130
HuR
NeuN
NF H/M

Marker for
microtubules
HuR ligand
mitochondria
cis-Golgi apparatus
mRNA BP
nucleus
intermediate
filaments
Endoplasmic
reticulum
HuR ligand

PDI
pp32

Vendor
Sigma
Abcam
Abcam
BD Biosciences
Santa Cruz
Millipore
Sigma-Aldrich

Catalog #
T6199
ab4224
ab16056
610822
sc-5261
MAB377
N2912

Dilution
1:100
1:100
1:50
1:100
1:25
1:500
1:300

Thermo Scientific

MA3-019

1:200

Enzo Life Sciences

ADI-905-234100
HPO-0100
2317
MA3-063

1:250

ImmunoVision
Cell Signaling
Thermo Scientific
Abbreviations and a brief description of the antigens is provided in the text.

RPA
S6
TGN38

60S subunit
40S subunit
trans-Golgi apparatus

1:5000
1:25
1:200

A. Animal Model
Unilateral focal brain ischemia was induced in male Long Evans rats (weight 275-300g;
Charles River Laboratories International, Inc., Wilmington, MA) using the same model of
MCAO described in Chapter 2. The experimental groups and number of animals used are listed
in Table 5.
Table 5: Experimental groups used in Long Evans studies.
Experimental Group
Sham controls
2I
2I/24R
4I
6I
8I

Ischemia
2hr
2hr
4 hr
6hr
8hr

Reperfusion
24 hr
-

n
3
5
5
5
5
5

III. Methods
A. TTC Staining
TTC staining was performed as previously described in Chapter 2.
B. Immunofluorescence and FISH
Double IF/FISH was performed exactly as described in Chapter 2. Primary antisera
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dilutions are listed in Table 4. Secondary antisera dilutions in 1% NDS in PBS-TX were the
same as that previously described in Chapter 2.
C. Systematic histological analysis of MCAO brain
As described in Chapter 1, focal ischemia results in heterogeneous damage in the brain
producing, at minimum, a core, penumbra, and the remaining nonischemic brain tissue.
Therefore, for all samples, each of these regions was analyzed. In addition, since the MCA feeds
both the cerebral cortex and striatum, I evaluated both regions histologically. The rat cerebral
cortex, while functionally six layered, shows 3 anatomical demarcations at the coronal levels I
investigated (around 1 mm anterior to Bregma). Layers II and III form one large layer most
proximal to the brain surface, under which are layers V and then VI. Thus, I routinely analyzed
4 histological regions: striatum, and layers II/III, V, and VI. In total, to systematically study the
brain after focal ischemia, for every experimental animal I routinely photographed from the 12
different areas in a given coronal section. The different MCAO-induced areas and histological
regions are illustrated in Figure 10.

Figure 10: Regions systematically analyzed in Long Evans MCAO brains.
Histological regions are listed on the left of the coronal section, and MCAO-induced areas are
displayed on the right hemisphere. The coronal section used for analysis of histological regions
was at approximately 1 mm anterior to Bregma. Purple area in sagittal inset shows the rostralcaudal extent used for 3D reconstructions described in section IV.D below. Images adapted and
modified from109.
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D. Volumetric reconstruction of pA staining
For computer reconstructions of the 3D rostral to caudal spatial distribution of neurons
containing mRNA granules, sixteen coronal slices, 100 microns apart, were evaluated between
approximately 1.32 mm to – 0.60 mm anterior to Bregma, containing the MCA territory.
Slices were stained by double labeling with pA FISH and PABP IF. Areas with mRNA
granules-containing neurons and areas with shrunken/distorted neurons (described in Results
below) were determined for each slice under 20X magnification and marked on photocopies of
corresponding coronal sections taken from the Paxinos and Watson Rat Brain Atlas109. Since
PABP strongly colocalizes with mRNA granules102, all mRNA granule-containing regions were
confirmed by inspection under the 40X objective for both pA and PABP stains. Determination
of areas containing neurons with either mRNA granules or with shrunken/distorted neurons was
conducted by two independent observers blinded to the identity of the experimental groups; the
independent mappings generally agreed to > 90%.
Hand-drawn images were then digitized as BMP files on a flat bed scanner and imported
into Amira 5.2.0 (Visage Imaging, San Diego, CA, USA) to perform 3D reconstructions. The
mRNA granule-containing and shrunken/distorted neuron-containing areas were traced onto
cross sections at approximately the same Bregma coordinates of the corresponding images of the
digital rat brain dataset from the Laboratory of Neuro Imaging (LONI) from the University of
California at Los Angeles110. The LONI dataset used was the series of coronal images through
the entire rat brain sampled at 30 micron intervals and digitized at 1024 x 1024 pixels, 8 bit
resolution. (This data is available for download at: www.loni.ucla.edu/Atlases/Atlas_
Detail.jsp?atlas_id=1)
For both illustration purposes and for quantitation (described below) the 3D reconstructed
volumes were embedded within the LONI dataset. The LONI dataset was masked to include
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only the brain, and volumetrically rendered in Amira from slice (using the exact file names of the
LONI dataset) cor_0979.gif (at Bregma -0.66 mm) through slice cor_1043.gif (at Bregma +1.34
mm) using the Voltex method with ‘mip’ (mean intensity projection) and ‘color table’ options
selected, and a constant color of RGB = (0.894, 0.894, 0.894).
From the 16 sequential brain sections of FISH/IF staining, 3D volumes were generated in
Amira 5.2.0 as per user manual instructions.

Two volumes were constructed per each

experimental animal: the volume containing shrunken/distorted neurons (colored red in the
figures and labeled “core”) and the volume of mRNA granule-containing neurons (colored green
in the figures and labeled “granular”). Magnitudes of each volume were taken as the number of
voxels contained in each volume as calculated by built-in Amira routines. The “total volume”
was taken as the number of voxels in one hemisphere of the masked LONI dataset between
coordinates +1.34 to -0.66 mm anterior to Bregma. “Total affected volume” was the sum of the
core and granular voxels in an animal. Two different percents were calculated to express the
volumetric data. Relative percent volume calculated the relative proportions of the core and
granular volumes occupying the total affected volume. Absolute percent volume calculated the
percent of the total LONI dataset volume occupied by the granular and/or core volumes.
Calculated percents for experimental groups were compared using ANOVA, and Tukey post hoc
where appropriate, with significance was set at p < 0.05. Using the pre-core volume as an
example, the percentage formulas were.
relative percent 

absolute percent 

# voxels pre- core
x100
# voxels pre- core + # voxels granular

# voxels pre- core
x100
# voxels in LONI dataset between Bregma +1.34 mm to - 0.66 mm
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IV. Results
A. TTC staining

When permanent MCAO (pMCAO) was evaluated out to 8 hr ischemia in the Long
Evans rats, none of the pMCAO samples showed an infarct by TTC staining (Figure 11).
However, TTC staining of Long Evans rats showed an infarct in the 2 hr ischemia plus 24 hr
reperfusion group (Figure 11). This result contrasts to the Wistar groups, where no infarct was
seen as far out as 7 days of reperfusion (Figure 5).
The 2I/24R TTC result provided a rough guide to our use of the terms “penumbra” and
“core” in the 3D reconstructions described below. In the pMCAO ischemia-only samples,
neurons located in the areas devoid of TTC staining in the 2I/24R samples generally had a
shrunken and distorted appearance, and often had weak staining for protein antigens. Therefore,
in spite of TTC staining the pMCAO brains from 2 to 8 hr ischemia-only, the neurons displayed
characteristics that are not revealed by TTC, but can be detected by other stains111, and are
indicators of damaged neurons that will eventually form the core of the infarct.

Long Evans
sham

4I

8I

2I/24R

Figure 11 : TTC staining in Long Evans rats subjected to
MCAO ischemia.
Representative 2mm thick brain slices are arranged
anterior (top) to posterior (bottom) and encompass the
MCAO territory, which includes the striatum.
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B. Frequency of mRNA granule formation

The total number of experimental Long Evans rats showed a much higher frequency of
mRNA granule formation (80%) (Table 6) than the total number of experimental Wistar animals
(11%) (Table 3). However, this is a misleading number because the experimental groups are not
directly comparable in terms of the total number of rats. The Wistar set consisted mainly of
transient MCAO, whereas the Long Evans set was mainly pMCAO. When compared in terms of
experimental groups, the Wistar and Long Evans had comparable frequencies: 67% of 2I Wistar
rats and 100% of the pMCAO groups of Long Evans rats had mRNA granules in some neurons.
We will see below, however, that the affected areas were much larger in the Long Evans strain.
Table 6: mRNA granule frequency in Long Evans rats.
Experimental Group
n tested
n w mRNA granules
2I
5
5
2I/24R
5
0
4I
5
5
6I
5
5
8I
5
5
total
25
20

Percent
100 %
0%
100 %
100 %
100 %
80%

C. Systematic histology of mRNA granules in Long Evans MCAO

Co-staining pairs of pA FISH with IF for S6, PABP and HuR were performed across the
12 areas illustrated in Figure 10. Three co-stains were performed per animal to compare to both
the Wistar results that used these stains and to compare to the previous work on global ischemia
in the Jamison et al. study102. There were two main questions I wanted to ask with these studies:
(1) Did mRNA granules form preferentially in any of the four histological regions: layer II/III,
layer V, layer VI and striatum? (2) Did mRNA granules form preferentially in any of the three
major MCAO-inducing brain areas: core, penumbra and (non-ischemic) contralateral
hemisphere? Representative samples for layers II/III and V are shown in Figure 12, and for layer
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VI and striatum in Figure 13. The samples shown are drawn mainly from the 2I and 4I groups.
The results to emerge from these studies are: (1) neurons of all 4 histological regions,
layers II/III, V, VI and striatum, formed mRNA granules, (2) the mRNA granule-containing
neurons were found preferentially in penumbral areas at the watershed between the MCA and
ACA, (3) their colocalization patterns with S6, PABP and HuR were similar to those seen in the
Wistar studies described in Chapter 2 and to those seen following global brain ischemia102, and
(4) shrunken/distorted neurons were present in the core areas fed directly by the MCA.
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sham

contralateral

penumbra

core

S6/pA

PABP/pA

HuR/pA

L2/3

10 m

sham

contralateral

penumbra

core

S6/pA

PABP/pA

HuR/pA

L5

10 m

Figure 12: Layers II/III and V: sham, contralateral, penumbral and core pA & S6, PABP or HuR
merged images. Scale bars in lower right panel apply to all panels for a given histological
region.
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contralateral

penumbra

core

S6/pA

PABP/pA

HuR/pA

L6

10 m

contralateral

penumbra

core

S6/pA

PABP/pA

HuR/pA

Striatum sham

10 m

Figure 13 : Layer VI and striatum: sham, contralateral, penumbral and core pA & S6, PABP or
HuR merged images. Scale bars in lower right panel apply to all panels for a given histological
region.
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In addition, the core neurons generally had a weaker staining for the protein antigen, but
the pA staining was good enough to discern the shape of the shrunken and/or distorted neurons.
Finally, in general, the neurons of the four histological regions on the contralateral side
resembled sham operated controls.
With regard to the colocalization patterns, in sham and contralateral neurons, S6 and
PABP formed diffuse colocalization. When neurons showed mRNA granules, S6 did not, but
PABP and HuR did colocalize with the mRNA granules. The colocalization with HuR was
strong enough to form distinctly yellow mRNA granules, unlike the Wistar strain, but similar to
CA3 following global brain ischemia102.
D. 3D Volumetric analysis

The above colocalization studies showed that neurons in all cortical layers and the
striatum could form mRNA granules, but there was quite a bit of variance in the distribution of
the granules amongst these regions. 3D volumetric reconstructions were generated as a means to
determine the relative distributions of neurons containing mRNA granules in the various regions.
The reconstructions also served to assess the extent of the ischemic insult through a rostral to
caudal extent in the brain.
A representative series of cross sections used to generate the 3D reconstruction of a 4I
sample is shown in Figure 14. The top panels illustrate the appearances of areas assigned as
either granular penumbra or shrunken/distorted core verses normal appearing, using the pA
FISH/PABP IF co-staining of layer II cortical neurons. The bottom panel of Figure 14 shows an
example of a 4I animal where mRNA-granule containing (green areas) and shrunken and
distorted neurons (red areas) appeared in rostral-caudal cross sections. These areas are shown
superimposed on the corresponding slices from the LONI rat brain dataset. Only half the dataset
used for volumetric reconstruction is illustrated in the figure, therefore each slice is separated by 200µ.
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normal

4I-1

mRNA granules

core

10 m

200 m

Bregma + 1.32

Bregma - 0.60
core

mRNA granules

Figure 14: Cross-sections used for 3D reconstructions in Long Evans strain after pMCAO.
Top: Example appearances of normal, granular and core areas in layer II. Scale bar on right panel
applies to all three panels of the top row. Bottom: Rostral to caudal cross-sections show the
extent of the granular penumbral (green) and core (red) areas through the MCA territory of a
representative 4I samples.

For this particular example, no striatal neurons showed evidence of mRNA granules. The
cells of the lateral striatum were shrunken and distorted, appearing similar to the top panel
marked “core”. Neurons of the medial striatum had the same appearance as contralateral and
sham-operated striatal neurons (e.g. as in Figure 13).

This animal also showed a substantial

fraction of cerebral cortex to have a core phenotype that ran for some distance across all the
cortical layers, mainly in somatosensory cortex. However, significant areas of cerebral cortex
contained neurons expressing cytoplasmic mRNA granules. These areas were mostly medial to
the core cortical areas, and were in the watershed area between the MCA and anterior cerebral
artery territory.
Using the sequential cross sections, 3D volumes for the penumbra and core phenotypes
over a range of pMCAO durations were generated (Figure 15). Quantitative analysis of the
volumes for the 3D reconstructions from the pMCAO groups are as follows: at 2hrI, 72.8 ±
38.5% of the affected volume had mRNA granule containing neurons, and 27.2 ± 38.5%
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contained distorted and shrunken cells. However, the relative volume percents did not clear
statistically. There was a drop in the relative proportion of the affected volume of neurons
containing mRNA granules to 15 ± 11.2%, 8.6 ± 8.0% and 0 % for the 4hrI, 6hrI and 8hrI groups
respectively, and corresponding increases for the volume of core neuron phenotypes.

The

relative percents for the 4I and 6I groups cleared statistically (ANOVA p < 0.05, Tukey p <
0.05). An exponential curve fit of the decrease in relative volume containing mRNA granules
(Figure 15, blue curve) gave a correlation coefficient (cc) equal to 0.91, whereas a linear fit gave
a cc of 0.77 (Figure 15, magenta curve). The exponential drop in mRNA granule-containing
neuron volume corresponds to expansion of the core into the penumbral region124, as ischemia
duration increases.
2hr pMCAO

4hr pMCAO

Percent affected volume
150%

n = 5/grp

125%
100%

6hr pMCAO

8hr pMCAO

core
mRNA granules

*

*

4hr

6hr

75%
50%
25%
0%
2hr

8hr

Exponential fit cc = 0.91 (blue)
Linear fit cc = 0.77 (magenta)

Figure 15: Quantification of mRNA granule-containing volumes in Long Evans pMCAO rats.
Left: Representative 3D reconstructions from 2, 4, 6 and 8 hr of pMCAO in Long Evans rats.
Right: Plot of percent affected volume occupied by mRNA granule-containing or core-like
neurons. Blue curve is an exponential fit through the penumbral percents, and magenta curve is
a linear fit. The correlation coefficients (cc) of the respective fits are indicated. There was a
statistically significant difference (post hoc p < 0.05) for the relative percents of penumbra and
core at the 4 hr and 6 hr experimental groups.
E. Colocalization in Layer II neurons

In this study, layer II/III mRNA granule forming neurons were assessed for
colocalization with markers of organelles (Figures 16-22) and mRNA binding proteins (Figures
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23-28). Figures 16-28 show staining in the three main MCAO regions: contralateral, penumbral
and core, the latter two terms used as above. For these studies the results are shown in terms of
the merged green and red channel and underneath are the individual green and red channels so
the patterns of staining in the individual channels can be directly inspected along with the
merged images. A summary of the staining patterns of the 13 antigens in the contralateral
neurons and with the mRNA granules is provided in Table 7.
1. Double IF/pA FISH and Intracellular Organelle markers

For the contralateral, nonischemic hemisphere, the only organelle marker to show some
degree of colocalization with pA mRNAs was protein disulfide isomerase (PDI, Figure 16), an
endoplasmic reticulum (ER) localized enzyme used in the formation of disulfide bond. This is
not unexpected, and the overlap of pA and PDI likely reflects the detection of rough ER, in
which ribosomes are localized on the surface of the ER membrane. This would bring mRNA
into close physical proximity to enzymes such as PDI.
However, in the penumbral neurons, the mRNA granules did not colocalize with PDI
(Figure 16), GM130 (Figure 17) or TGN38 (Figure 18). GM130 is a 130 kDa “Golgi marker”
protein localized to cis-Golgi. The 38 kDa trans-Golgi network marker localizes the trans-Golgi.
The lack of colocalization indicates mRNA granules are not associated with the internal
membranes making up the proximal secretory apparatus of the cell. The mRNA granules did not
colocalize with cytochrome c oxidase, subunit IV (COX IV), an inner mitochondrial membrane
protein involved in electron transport (Figure 19). Nor did they colocalize with α-tubulin (Figure
20) or with an antisera that detects the heavy (H) and medium (M) weight neurofilament proteins
(NH-H/M, Figure 21) and thereby do not interact with microtubules or neuronal intermediate
filaments, respectively. Unexpectedly, the mRNA granules did colocalize with the widely used
neuronal marker, NeuN (Figure 22). “NeuN” is an abbreviation of “neuronal nuclei”, and I used
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this antiserum as a nuclei marker. However, we were surprised to observe the NeuN signal
clearly colocalized with the mRNA granules outside of the nucleus. In sum, these results
indicate that mRNA granules do not associate with the organelle markers tested.
2. Double IF/pA FISH and mRNA binding proteins

In the non-ischemic contralateral neurons, the one mRNA binding protein that strongly
colocalized with cytoplasmic pA was ribosome p antigen (RPA, Figure 23) a marker of the large
60S ribosomal subunit112. Similar to S6, such colocalization would be expected to reflect mRNA
associated with translating ribosomes. The only other markers that showed colocalization with
pA in the contralateral neurons were TIA-1 and pp32. This colocalization occurred in the form
of small punctate spots in the cytoplasm. Based on Foaz Kayali’s work101, we now know the
TIA-1/pA spots in the cytoplasm are stress granules.
For the penumbral layer II neurons, the mRNA granules did not colocalize with RPA just
as they did not colocalize with S6 (e.g. see pA/S6 co-stains in Figure 12 and Figure 13). Thus,
the mRNA granules are sequestered away from the entire ribosome, both 40S and 60S subunits.
The mRNA granules colocalized with HuR, an mRNA binding protein (Figure 24), but did not
colocalize with the HuR cofactors APRIL and pp32 (Figures 25 and 26, respectively). ARPIL
and pp32 are involved in the nuclear to cytoplasmic mRNA transport function of HuR113. The
mRNA granules did not colocalize with the stress granule marker, TIA-1 either (Figure 27),
ruling out the possibility of being stress granules. Lastly, there was no colocalization of the
mRNA granules with TTP, an mRNA destabilizing protein that is associated with degradative
processing bodies.114 Based on the results here, mRNA granules that form following focal
ischemia behave the same as those that occur following global ischemia102, binding well-known
mRNA binding proteins and sequestering mRNA away from ribosomal machinery.
Finally, it is striking that for each antigen studied, there is a decrease in protein antigen
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staining in core neurons. Technically, this cannot be due to interference by the poly(T) probe
because the FISH procedure is performed after the IF procedure.

Contralateral

Ipsilateral penumbra

Ipsilateral core
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Figure 16: Layer II colocalization studies in Long Evans for pA & PDI.
Double FISH/IF for poly-adenylated mRNAs [p(A), green channel], and PDI (protein disulfide
isomerase), a marker of the endoplasmic reticulum (red channel) in layer II of cerebral cortex
following 2 hrs permanent MCAO ischemia. Images taken from coronal section approximately 1
mm anterior to Bregma using the coordinates of Paxinos and Watson (1998). Scale bar in lower
right panel is 10 microns and applies to all panels.
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Figure 17: Layer II colocalization studies in Long Evans for pA & GM130.
Double FISH/IF for poly-adenylated mRNAs [p(A), green channel], and GM130, a marker of the
cis-Golgi Apparatus (red channel) in layer II of cerebral cortex following 2 hrs permanent
MCAO ischemia. Images taken from coronal section approximately 1 mm anterior to Bregma
using the coordinates of Paxinos and Watson (1998). Scale bar in lower right panel is 10
microns and applies to all panels.
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Figure 18: Layer II colocalization studies in Long Evans for pA & TGN38.
Double FISH/IF for poly-adenylated mRNAs [p(A), green channel], and TGN38, a marker of the
trans-Golgi Network (red channel) in layer II of cerebral cortex following 2 hrs permanent
MCAO ischemia. Images taken from coronal section approximately 1 mm anterior to Bregma
using the coordinates of Paxinos and Watson (1998). Scale bar in lower right panel is 10
microns and applies to all panels.
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Figure 19: Layer II colocalization studies in Long Evans for pA & COX IV.
Double FISH/IF for poly-adenylated mRNAs [p(A), green channel], and COX IV (cytochrome c
oxidase, subunit 4), a marker of the mitochondria (red channel) in layer II of cerebral cortex
following 2 hrs permanent MCAO ischemia. Images taken from coronal section approximately 1
mm anterior to Bregma using the coordinates of Paxinos and Watson (1998). Scale bar in lower
right panel is 10 microns and applies to all panels.

66

Contralateral

Ipsilateral penumbra

Ipsilateral core
merge

p(A) -green

-tubulin - red

10 m

Figure 20: Layer II colocalization studies in Long Evans for pA & α-tubulin.
Double FISH/IF for poly-adenylated mRNAs [p(A), green channel], and α-tubulin, one of the
main proteins of the microtubule component of the cytoskeleton (red channel) in layer II of
cerebral cortex following 2 hrs permanent MCAO ischemia. Images taken from coronal section
approximately 1 mm anterior to Bregma using the coordinates of Paxinos and Watson (1998).
Scale bar in lower right panel is 10 microns and applies to all panels.
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Figure 21: Layer II colocalization studies in Long Evans for pA & neurofilaments H and M.
Double FISH/IF for poly-adenylated mRNAs [p(A), green channel], and neurofilaments H and
M (NF-H/M), a marker of the intermediate filament component of the cytoskeleton (red channel)
in layer II of cerebral cortex following 2 hrs permanent MCAO ischemia. Images taken from
coronal section approximately 1 mm anterior to Bregma using the coordinates of Paxinos and
Watson (1998). Scale bar in lower right panel is 10 microns and applies to all panels.
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Figure 22: Layer II colocalization studies in Long Evans for pA & NeuN.
Double FISH/IF for poly-adenylated mRNAs [p(A), green channel], and NeuN, a marker of
neuronal nuclei (red channel) in layer II of cerebral cortex following 2 hrs permanent MCAO
ischemia. Images taken from coronal section approximately 1 mm anterior to Bregma using the
coordinates of Paxinos and Watson (1998). Scale bar in lower right panel is 10 microns and
applies to all panels.
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Figure 23: Layer II colocalization studies in Long Evans for pA & RPA.
Double FISH/IF for poly-adenylated mRNAs [p(A), green channel], and RPA, a marker of the
large ribosomal subunit 60S (red channel) in layer II of cerebral cortex following 2 hrs
permanent MCAO ischemia. Images taken from coronal section approximately 1 mm anterior to
Bregma using the coordinates of Paxinos and Watson (1998). Scale bar in lower right panel is
10 microns and applies to all panels.
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Figure 24: Layer II colocalization studies in Long Evans for pA & HuR.
Double FISH/IF for poly-adenylated mRNAs [p(A), green channel], and HuR, an mRNA
binding protein that stabilizes adenine and uridine rich element (ARE)-containing mRNAs, in
layer II of cerebral cortex following 2 hrs permanent MCAO ischemia. Images taken from
coronal section approximately 1 mm anterior to Bregma using the coordinates of Paxinos and
Watson (1998). Scale bar in lower right panel is 10 microns and applies to all panels.
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Figure 25: Layer II colocalization studies in Long Evans for pA & APRIL.
Double FISH/IF for poly-adenylated mRNAs [p(A), green channel], and APRIL (acidic protein
rich in lysine), a HuR accessory protein (red channel) in layer II of cerebral cortex following 2
hrs permanent MCAO ischemia. Images taken from coronal section approximately 1 mm
anterior to Bregma using the coordinates of Paxinos and Watson (1998). Scale bar in lower right
panel is 10 microns and applies to all panels.
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Figure 26: Layer II colocalization studies in Long Evans for pA & pp32.
Double FISH/IF for poly-adenylated mRNAs [p(A), green channel], and pp32 (red channel), a
HuR accessory protein involved in mRNA nuclear export in layer II of cerebral cortex following
2 hrs permanent MCAO ischemia. Images taken from coronal section approximately 1 mm
anterior to Bregma using the coordinates of Paxinos and Watson (1998). Scale bar in lower right
panel is 10 microns and applies to all panels.
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Figure 27: Layer II colocalization studies in Long Evans for pA & TIA-1.
Double FISH/IF for poly-adenylated mRNAs [p(A), green channel], and TIA-1 (red channel) , a
canonical component of stress granules in layer II of cerebral cortex following 2 hrs permanent
MCAO ischemia. Images taken from coronal section approximately 1 mm anterior to Bregma
using the coordinates of Paxinos and Watson (1998). Scale bar in lower right panel is 10
microns and applies to all panels.
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Figure 28: Layer II colocalization studies in Long Evans for pA & TTP.
Double FISH/IF for poly-adenylated mRNAs [p(A), green channel], and TTP (red channel), an
enzyme involved in mRNA degradation and localized to processing bodies, in layer II of
cerebral cortex following 2 hrs permanent MCAO ischemia. Images taken from coronal section
approximately 1 mm anterior to Bregma using the coordinates of Paxinos and Watson (1998).
Scale bar in lower right panel is 10 microns and applies to all panels.
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mRNA binding proteins

Organelle Markers

Table 7: Summary of mRNA granule colocalization in Long Evans rats with pMCAO.
Figure
CL with
CL with pA in
Antigen
Marker of
No.
mRNA
contralateral
granules
cytoplasm
Endoplasmic
partial
No
16
PDI
reticulum

GM130

Cis-Golgi

No

No

17

TGN38
Cytochrome C
oxidase subunit
IV

Trans-Golgi

No

No

18

Mitochondria

No

No

19

α-tubulin
Neurofilament
H/M

Microtubules
Intermediate
filaments

No

No

20

No

No

21

NeuN

Nucleus

No

Yes

22

Ribo P antigen

60S subunit

Yes

No

23

HuR

mRNA BP

No

Yes

24

APRIL

HuR cofactor

No

No

25

pp32

HuR cofactor

Minor, punctate

No

26

TIA-1

Stress granules Minor, punctate

No

27

TTP

Processing

No

27

No

bodies
CL, colocalization. Other abbreviations as defined in the text.
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CHAPTER FOUR: Effect of Diabetes - Methods and Results
I. Rationale

The systematic characterization of mRNA granule formation as a function of pMCAO
duration in the Long Evans rat strain described in the previous chapter laid the framework to
study the effect of diabetes on mRNA granule formation during focal cerebral ischemia.
Combining the well-known fact that diabetes worsens outcome after focal ischemia with the new
insight obtained from the time course and 3D distribution of neurons containing mRNA granules
as a function of pMCAO duration described in Chapter 3 (Figure 15), it seemed reasonable to
anticipate that diabetes might serve to accelerate the time course such that cessation of mRNA
granule formation occurred at an earlier duration of pMCAO than the 8 hr pMCAO in the nondiabetics. I therefore repeated the design of the experimental groups in Chapter 3, but shortened
the time course of pMCAO to cover the range 30 min to 6 hrs. Quite unexpectedly, this change
did not make a difference to the results. As we describe in this chapter, diabetes completely
inhibited mRNA granule formation in neurons during pMCAO.
II. Materials

STZ was purchased from Sigma Chemical Co. (St. Louis, MO). All other materials used
were previously described in Chapters 2 and 3.
III. Methods
A. Animal model

An insulinopenic model of diabetes was induced in 8-week old male Long Evans rats by
a single intraperitoneal (IP) injection of STZ (50 mg/kg dissolved in 0.1 mM sodium citrate, pH
4.5)104,115. Left hind limb saphenous vein blood samples were collected one week after STZ
injection and plasma glucose was determined using an Accu-Chek® Advantage glucometer
(Roche Diagnostics, Indianapolis, IN). Diabetes was defined by a blood glucose > 300 mg/dl,
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with animals being used 4-6 weeks later without insulin supplements. Average blood glucose for
the STZ-treated rats at the time of MCAO was 437 mg/dL ± 49.5. Unilateral focal brain ischemia
was induced using the same model of MCAO described in Chapter 2. Diabetic experimental
groups are listed in Table 8. NIC-d is the sham operated diabetic rats not subject to MCAO.
Table 8: Diabetic Long Evans experimental groups.
Experimental Group
Ischemia
Reperfusion
NIC-d
0.5I-d
30 min
1I-d
1hr
2I-d
2 hr
4I-d
4hr
6I-d
6hr
-

n
3
4
4
4
4
4

B. TTC staining

TTC staining was performed as described in Chapter 2. Only the 6I-d group was stained.
C. Immunofluorescence (IF) and Fluorescent in situ hybridization

Double-labeling PABP IF and pA FISH were performed as described in Chapter 2.
D. Volumetric reconstruction of pA staining

3D reconstruction of the brain following diabetes plus pMCAO
was performed exactly as described in Chapter 3.
IV. Results
A. TTC staining

TTC staining was used to evaluate infarct volume in
insulinopenic, chronically diabetic male Long Evans rats. Representative
samples are shown in Figure 29. The NIC-d showed normal, deep red
TTC staining, as did the 6I-d group. Since no infarct was observed in the
6I-d group, earlier time points of pMCAO were not tested for TTC
Figure 29 : TTC staining in
6 hr Long
pMCAO.
staining. Figure 29: TTC staining in diabetic Long Evans rats following
diabetic
Evans rats
following 6 hr pMCAO
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B. Animal condition and mRNA granule frequency

Diabetic animals had average blood glucose of 437 ± 49.5 mg/dl and average weight loss
of 4.57 ± 0.53 grams. This weight loss was not different from the variance of non-diabetic Long
Evans used in Chapter 3. Three of the animals displayed muscle wasting and two of them
developed cataracts.
Following histological examination of pA FISH/PABP IF stained slides no mRNA
granules were detected in any neurons in any diabetic pMCAO group. The diabetic animals
showed only shrunken and distorted, core-like areas of pA/PABP staining (data not shown, but
essentially identical to Figure 14, top panel, core sample). Therefore, extensive colocalization
studies such as described in Chapters 2 and 3 could not be performed.
C. Volumetric analysis

Volumetric analysis was performed as previously described in Chapter 3. Using the
sequential cross sections, 3D volumes for the distorted/shrunken core neuronal phenotype of the
experimental groups was generated (Figure 30). As indicated above, no mRNA granules were
observed in neurons at any pMCAO duration, and therefore, reconstructed volumes show only
the volumes of shrunken distorted neurons in red. Unlike the non-diabetics, some of the diabetic
samples showed shrunken distorted neurons in the contralateral hemisphere and representative
samples are shown for the 4I-d and 6I-d samples in Figure 30. One of the 1I-d samples and two
each of the 4I-d and 6I-d samples showed bilateral damage. The volume of shrunken/distorted
neurons in the contralateral hemisphere did not exceed 10% of the total affected volume.
Since no mRNA granules formed in neurons of diabetic MCAO animals, relative
volumes could not be calculated. Instead, the “absolute” percent of affected brain was taken as
the volume of core divided by the volume of one hemisphere of the LONI dataset and is plotted
in Figure 30 (brown curve). In the 0.5I-d group, 27.7 ± 6.5% of the hemisphere volume had
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shrunken/distorted neurons and this increased to 40.1 ± 9.0%, 46.9 ± 14% and 49.2 ± 17% at 1I,
4I and 6I, respectively. There was no statistical difference amongst the diabetic 1I, 4I and 6I
groups, however, the 0.5I-d group differed statistically from the aforementioned groups
(ANOVA p = 0.044, Tukey post hoc p = 0.032).
Also shown on the plot of Figure 30 is the percent of the LONI hemisphere volume taken
up by the sum of the non-diabetic mRNA granule and non-diabetic core volumes (which had
been shown as relative percents in Figure 15). When summed in this fashion the 1I, 2I, 4I and 8I
percents of the LONI volume were 50.0 + 26.9 %, 60.6 + 15.8 %, 68.7 + 11.3 %, and 63.7 + 0.0
%, respectively.

None of these summed volumes cleared statistically.

Further, when an

ANOVA was run comparing the 2I and 4I pMCAO time points between the diabetic and non-

Percent of LONI dataset volume

diabetic samples, these did not clear statistically (ANOVA p = 0.327).

100%
non-diabetic

75%

50%

diabetic

*

25%

0%
0

2

4

6

8

10

duration of pMCAO (hr)

Figure 30: 3D reconstructions following pMCAO in diabetic rats.
Left: Representative 3D reconstructions of volumes of tissue containing shrunken/distorted
neurons as identified by PABP/pA IF/FISH. Right: Percent of one hemisphere of the LONI
dataset occupied by the core volume in diabetics (brown curve) or the core plus mRNA granulecontaining volumes of the non-diabetics (cyan curve). The red and green curves are the averages
of the volumes of the core and mRNA granule volumes, respectively, that are summed together
to form the cyan curve. Red and green curves are shown for reference, and are shown without
error bars to minimize distractions on the chart. Error bars on the cyan curve are the combined
errors of the sum of the red and green curves. * Post hoc p < 0.05 for 0.5I-d compared to other
diabetic groups.
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There are two interesting conclusions drawn from the plot in Figure 30. First, diabetes
did not increase the total volume of tissue affected by the pMCAO. The total volumes in both
the diabetic and non-diabetic samples converged to roughly 50% of the reference volume, which
was taken as one hemisphere of the rendered LONI dataset. Instead, and contrary to my
hypothesis, diabetes did not increase the extent of injury after MCAO; it completely inhibited
formation of the mRNA granules at any time point of MCAO.
Second, when the non-diabetic data is expressed as a percent of the reference volume, the
sum of the mRNA granule-containing volume and the core volumes was essentially constant. As
can be seen from the red and green lines on the plot of Figure 30, there was an exponential
conversion of the mRNA granule containing volume to core volume as the duration of pMCAO
increased.
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CHAPTER FIVE: Discussion
I. Summary of Results

In the previous chapters I have described my studies assessing the histology of pA
mRNAs in the rodent brain following focal ischemia. My main findings were:
1. In Wistar rats no infarct was detected out to 7 days reperfusion after 2 hr MCAO.
Granulation of mRNA was sporadic and occurred at low frequency only in the 2I samples
and was unaffected by anesthetic. The mRNA granules detected had the colocalization
properties seen after global brain ischemia102.
2. The frequency of mRNA granule-containing neurons was much greater in the Long Evans
rat strain in the 2I group compared to the Wistar strain. Following 2 hr MCAO and 24 hr
reperfusion, Long Evans rat brains showed a necrotic core.
3. The mRNA granules in the Long Evans rats following pMCAO…
a. Were detected in layers II/III, V and VI of cerebral cortex, and striatum, and
they occurred in ipsilateral penumbra.
b. Had the colocalization properties seen after global brain ischemia102.
c. Did not colocalize with markers of ribosomal subunits or organelles but did
colocalize with NeuN.
d. Decreased in frequency with increased during of pMCAO and were not
detected in the 8I group.
4. The volume occupied by mRNA granule-containing neurons transformed into a core-like
shrunken and distorted neuronal phenotype with increased duration of pMCAO.
5. Diabetes inhibited formation of mRNA granules in neurons at all durations of pMCAO
tested.
6. The volume of tissue showing distorted/shrunken neurons in diabetic samples approached
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the same volume of core tissue in non-diabetics with increased duration of pMCAO.
In this chapter I will discuss the significance of these findings with respect to other
studies in the literature and also with respect to new insights they provide about the response of
the brain to focal ischemia and the response of the diabetic brain to focal ischemia.
II. Differences between Rat Strains

To begin, there was a striking difference in the way the Wistar and Long Evans rats
responded to MCAO ischemia. Previous studies from other labs indicate a number of factors that
would predispose the Wistar strain to be more resistant to a given ischemic stimulus compared to
the Long Evans strain.
A. Strain Differences in Outcome

Wistar rats, compared to other common laboratory rat strains, were shown to have a
greater number of MCA-ACA anastomoses or collaterals106. Collateral flow becomes important
during focal ischemia to compensate in regions downstream of a focal occlusion124 to increase
blood flow to core and penumbra116. The importance of collateral flow was demonstrated by
Oliff et al. who showed that when collateral flow was reduced by bilateral CCA occlusion, there
was a significant increase in the mean cortical infarct volume116,124. In addition, subcortical
regions like the striatum receive blood supply almost exclusively from the lateral striate arteries
that originate from the MCA. Since these arteries are end-arterioles, the caudate-putamen does
not receive sufficient collateral blood flow to keep the tissue viable following MCAO106. Most
of the strain difference findings suggest that variations in outcome of focal ischemia may not be
a technical issue, but may have to do with the type of animals used116. Thus, increased collateral
blood flow is one explanation of why Wistar rats were more resistant to focal ischemia compared
to Long Evans rats106,116.
In addition to vascular anatomical differences, using laser Doppler flowmetry, Long
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Evans rats demonstrated a more persistent and pronounced stable drop in cortical local cerebral
blood flow (LCBF) (74.6 ± 8.9%) following 60 minutes of transient MCAO when compared to
Wistar rats (49.0 ± 21.9%)117. The differences in blood flow could not be fully accounted for by
anatomical differences in the vasculature and these authors speculated that intrinsic blood flow
regulatory mechanisms may be more robust in the Wistar strain.
Factors such as these, allowing Wistars to maintain a higher blood flow during the
MCAO period, could explain why, after 2 hr MCAO, the Wistar rat failed to show an infarct
even out to 7 days reperfusion and the Long Evans strain showed an infarct at 24 hr reperfusion.
B. Strain Differences in mRNA granule Formation

The studies described above can also be used to explain why the incidence of mRNA
granule formation was so much less in the Wistar compared to the Long Evans rats. Work from
Hossmann’s lab has measured many different metabolic and functional thresholds that occur at
specific decrements of cerebral blood flow (CBF)124. For example, CBF must decrease below
20% for ATP levels to drop precipitously and for neurons to dissipate ion gradients118.
Hossmann has documented that the threshold for TA occurs at ~ 50% reduction in CBF119.
Based on the CBF study conducted by Prieto et al117, CBF during MCAO averages around 50%
in the Wistar, but averages around 30% for the Long Evans. Thus, the Wistar, on average,
hovers at the threshold of TA onset, but the Long Evans is substantially below the 50% CBF
threshold. Formation of mRNA granules has been shown to be a morphological correlate of
TA102, specifically because mRNA is sequestered away from ribosomal subunits. Therefore, the
same explanation for improved outcome in the Wistar strain also provides a plausible
explanation for the relative lack of mRNA granule formation following MCAO in this strain.
Although protein synthesis was not directly measured in the studies described here, my results
lead to the prediction that there would not be a cessation of protein synthesis in the Wistar brain
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at least out to 2 hr MCAO and for any subsequent reperfusion duration. Indirect support for this
prediction from the present studies was that I observed the successful translation of HSP70
protein in the Wistar strain at various durations of reperfusion (Figure 9). It is well documented
that HSP70 translation does not occur in neurons destined to die by DND in both focal and
global brain ischemia models, specifically because of the prolonged TA1,86.
III. mRNA Granules in Focal Ischemic Neurons

Our previous study showed mRNA granules form following global brain ischemia102.
The present study is the first demonstration of mRNA granule formation following focal brain
ischemia. I performed extensive colocalization studies (Figure 12 and Figure 13) in order to
determine if the mRNA granules that formed following focal ischemia were the same as those in
the global model. Furthermore, I have extended the colocalization studies beyond those we
published in the global model to assess cell organelles and additional mRNA binding proteins
(Figures 16-28).
As stated above, the mRNA granules seen after MCAO failed to colocalize with the 40S
and 60S ribosomal subunits. Presently, this is their most important characteristic as it provides
an explanation for what has been an outstanding unresolved problem in the field, which is the
cause of prolonged TA in post-ischemic brain neurons.
However, the additional colocalization studies begin to address more specifically what
the mRNA granules are, and are not. They did not colocalize with markers of the ER or for cisand trans-Golgi network. Thus, even though the mRNA granules are intimately involved with
the translational system, they are not involved in the main proximal secretory systems for
secreted and membrane localized protein synthesis.

I also tested two markers of the

cytoskeleton: -tubulin and neurofilament proteins H/M. The lack of colocalization indicates the
mRNA granules are not formed in association with microtubules or intermediate filaments. I had
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tried several actin antibodies to look at the actin system, but was unable to get any of the tested
actin antibodies to work in the FISH/IF double labeling procedure. Thus, the association of
mRNA granules with the microfilament system is unresolved by my studies. The mRNA
granules also did not colocalize with COX IV, a mitochondrial marker. Therefore, my studies
rule out these organelle systems as playing a direct role in mRNA granule function.
Similar to the results with global brain ischemia102, the mRNA granules did not
colocalize with TIA-1 or TTP and therefore are not stress granules or processing bodies. They
did colocalize with the known mRNA binding proteins PABP and HuR. Thus, the mRNA
granules observed in the focal model are very similar to, if not identical to, those observed
following global brain I/R.
However, one surprising finding was the colocalization of the cytoplasmic mRNA
granules with NeuN, a neuronal nuclei marker. A recent study identified NeuN as the sequencespecific mRNA splicing factor Fox-3. Fox-3 is a component of nuclear speckles, which are
morphological structures of the nuclear transcription and mRNA processing machinery that
interacts with the nuclear matrix120. That NeuN has been identified as a protein involved in
nuclear mRNA processing is consistent with our observation that NeuN colocalized in the
mRNA granules. Furthermore, our result suggests that NeuN may function similarly to TIA-1,
TTP and HuR, all of which are nuclear proteins involved in mRNA processing, but which
translocate to the cytoplasm during cell stress and play roles in the ribonomic systems76-81.
Since the mRNA granules colocalized with HuR, we tested two proteins known to
function with HuR during the heat shock response: APRIL and pp32. Both of these proteins
bind to and complex with HuR and its client mRNAs to mediate nuclear to cytoplasmic
translocation of mRNAs upregulated during heat shock79,80. The logic of testing APRIL and
pp32 was that if they colocalized with HuR and the mRNA granules, it would suggest all three
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proteins were playing a role in the nuclear export of mRNAs. However, neither APRIL or pp32
colocalized in the mRNA granules, and this suggests HuR may be mediating a function different
from that identified by the Steitz lab79.
To summarize the colocalization studies, the mRNA granules detected after MCAO share
the same characteristics as those seen after global ischemia, indicating they are likely the same
structures. Further, the mRNA granules are not substantially colocalized with organelles but
only select mRNA binding proteins.
IV. Time Course of mRNA granules in pMCAO

The observation that the relative proportions of mRNA granule-containing neurons
decreased with pMCAO (plot, Figure 15), but that the sum of the volumes of mRNA granulecontaining plus core-like neurons remained constant with pMCAO duration (plot, Figure 30) is
one of the significant findings of my work. This observation is relevant to how penumbral
neurons convert to core neurons and my findings contribute new insights to how this occurs.
As stated in the Background, rescuing the penumbra in an effort to improve outcome
following an ischemic event is the goal of stroke research. There are two general approaches to
stroke therapy. Therapies that induce reperfusion have had some success via surgical techniques
and with application of tissue plasminogen activator (tPA). But even tPA usage occurs at the
risk of hemo-compromising patients121. Neuroprotective strategies to halt the cause of cell death
of penumbral neurons have been spectacular failures: every single one of over 100 clinical trials
of stroke neuroprotection have failed122,123.

Thus, the new insights into how potentially

salvageable penumbral neurons convert to core-like neurons irreversibly committed to die are
significant for the possibility of offering new neuroprotective strategies in the long run.
There are different mechanisms of penumbra-core conversion whether focal ischemia is
transient or permanent, and whether the ischemia is occlusive or hemorrhagic124. Since I only
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investigated permanent occlusive focal ischemia, my work applies only to this case.
The two images shown in Figure 31 are taken from a 2009 review by Hossmann on the
pathophysiology of stroke injury and show the changes in the brain following pMCAO. The plot
in Figure 31A shows how blood flow changes throughout the core area as a function of pMCAO
duration.

CBF is initially at its lowest, but increases somewhat as collateral circulation

compensates for the occlusion. It should be noted he shows CBF to decrease to zero, but above I
discussed that the average CBF decreases during rodent MCAO range from ~ 20-50% normal
CBF.
The plot in Figure 31B shows the evolution of the infarct core with pMCAO duration. It
can be seen how this rapidly increases and is almost maximum at 3 hr pMCAO and is maximum
by 6 hr pMCAO. I have added to Figure 31B the curve of my results of the decrease in the
volume of tissue where the neurons contained mRNA granules (green curve). It is striking that
the decrease in mRNA granules is roughly a mirror image of the evolution of the infarct core.
This decrease occurs in spite of the minor increase in CBF shown in the plot in A. Thus, the loss
of ability of neurons to form mRNA granules directly correlates with production of infarct core.
It is also significant that I observed a rapid loss of mRNA-granule containing neurons
between 2 and 4 hr pMCAO. This is precisely the time window that Hossmann has indicated as
“therapeutic window” on his plot in Figure 31B. This correspondence would suggest that if we
understood exactly why the neurons lost the ability to form mRNA granules with increased
pMCAO duration, that this might be an important therapeutic target, and perhaps extend the
duration of the “therapeutic window” shown in Dr. Hossmann’s graph.
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B

Figure 31: Changes in blood flow and core evolution during pMCAO. Adapted from 124.

V. Inhibition of mRNA Granulation by Diabetes

It was an unexpected finding that diabetes led to a complete inhibition of mRNA granule
formation. It is well known that chronic diabetes causes a plethora of complications all of which
have a negative impact on stroke outcome. These can be classified into three general categories:
immunological, vascular and cellular. Each could plausibly contribute to the inhibition of the
mRNA granules.
There is a series of processes in the inflammatory response that are associated with postischemic reperfusion that exacerbate brain injury even when diabetes is not present115.

Chronic

diabetes induces exaggerated inflammatory responses to brain I/R due to increase in leukocyte
adhesion and emigration mediated by CD11/CD18-ICAM-1 and P-selectin and albumin
leakages125. Matrix metalloproteinases (MMP), which are involved in the physiological turnover
of the extracellular matrix, contribute to blood brain barrier leakage and cellular damage
following focal brain I/R. MMP-2 and MMP-9 have been implicated in cerebral ischemia.
MMP-9 is normally absent in brain but upregulated in response to injury. Early inhibition of
MMP-9 led to reduction in infarct size at two weeks following permanent MCAO125. Such

89
adverse inflammatory responses would converge to create an extracellular environment that
would upset the highly specific conditions required for neuronal function.

In this way,

inflammatory factors would serve to generally decrease neuronal fidelity, and this may
contribute to diabetes inhibition of mRNA granule formation.
There is an increased risk of endothelial cell dysfunction and vascular smooth muscle
impairment associated with chronic diabetes.19 Diabetics were also shown to have impaired
endothelium-dependent, nitric oxide-mediated vasodilation126.

Hyperglycemia inhibits the

production of nitric oxide via eNOS activation, thus blocking a potent vasodilator. Furthermore,
when diabetes is present, there is also an increase in the production of vasoconstrictors, such as
endothelin-1127.
diabetes.128.

Studies have also shown impairment in collateral recruitment in chronic

Such vascular abnormalities in chronic diabetes may also contribute to the

inhibition of mRNA granules in penumbral neurons, following diabetic MCAO. The vascular
abnormalities would collectively serve to increase the intensity of the ischemic insult following
MCAO, rendering the neurons incapable to respond properly to stress and leading to a greater
volume of core-like neurons.
Finally, diabetes alters intracellular conditions in generally adverse ways. Examples
include: decreased pH of the cytoplasm129, increased production of free radical species130,131,
inhibition of the oxidative phosphorylation of mitochondria132, and the activation of the intrinsic
apoptotic pathways96,104. All of these are direct forms of damage inside the neuron, and as such,
they could converge to inhibit the molecular mechanism of mRNA granule formation. For
example, one could hypothesize that some crucial or rate limiting component needed for the
formation of the mRNA granules is damaged by oxidative stress, or altered intracellular pH,
rendering them inactive. Another possible mechanism is that some crucial component of the
mRNA granules is a substrate of caspase 3 and degraded.

90
Thus, there are a number of plausible, experimentally testable hypotheses as to why
diabetes inhibits mRNA granule formation.
VI. Limitations of the Present Studies

There are several limitations of the present study.
1.

On one hand, the present study could be considered to be purely descriptive. There were
no drug interventions or genetic knockouts used in the present work in the attempt to
establish mechanism by the currently acceptable route. On the other hand, a histological
demonstration that mRNA does not colocalize with ribosomal subunits is itself a
mechanism of TA, one that has eluded 40 years of biochemical and molecular biological
studies on ischemic brains. Whether one frames the present work as descriptive or
mechanistic, it has clearly identified new phenomena that open up new and clinically
important lines of research into two of the biggest clinical problems today: stroke and
diabetes.

2.

No attempt was made to ascertain information about molecular mechanisms of the
formation or the function of the mRNA granules. However, that diabetes inhibits their
formation provides a system that can be used in the future to begin to address the
mechanisms of their formation.

3.

As described in the previous section, diabetes leads to a large number of possible
mechanisms for the inhibition of mRNA granule formation. The present studies did not
investigate any of these.

VII. Future Directions

Future directions follow directly from the limitations of the present study:
1.

Seek information about the molecular mechanisms of mRNA granule formation, and
about their role and function in the neurons of the ischemic and reperfused brain. Some
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ways to begin to move in this direction would be to use specific pharmacologic agents or
to use genetic knockouts to assess the role of specific proteins in either mRNA granule
formation of function. For example, as described in Background, Ca2+ ion is a critical
trigger for many subsequent molecular changes in the neurons after ischemia. Calcium
channel blockers or NMDA antagonists could be used to determine if Ca2+ also plays an
upstream role in mRNA granule formation. Another example would be to administer
agents that directly alter the translational system. For example, cycloheximide is a well
known protein synthesis inhibitor whose mode of operation is to prevent polysomes from
dissociating. Since it is well known that polysomes dissociate in neurons after I/R, would
preventing their dissociation with cycloheximide alter mRNA granule formation?
Genetically altered mice could also be used in a similar fashion to test the role of specific
proteins.
2.

The present work studied specifically mRNA granules after pMCAO. Now that the time
course of mRNA granule formation in pMCAO has been identified, the next step is to
study a time course of transient MCAO, and assess the mRNA granules and how they
correlate with outcome. For example, I can now predict that following 2hr MCAO, there
should be mRNA granules for at least some duration of subsequent reperfusion.
However, following 8 hr MCAO, there should be no mRNA granules at subsequent
reperfusion durations.

3.

Another future direction is to begin to study specific adverse effects of diabetes to see
which may be involved in the inhibition of mRNA granule formation.

Some of these

effects can be separated from diabetes, such as hyperglycemia.
VIII. Summary and Conclusions

I had hypothesized that mRNA granules form in brain after focal ischemia. My research
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showed how this phenomenon is dependent on the strain used, which, based on information from
the literature, was related to blood flow rates during MCAO, and hence the amount or degree of
ischemia generated in the different rat strains.

I have contributed new insights into how

penumbral brain tissue converts to core as ischemia duration increases. Neurons that might have
survived at lesser durations of focal ischemia no longer form mRNA granules with increased
ischemia duration.

Previously this had been understood only in terms of “threshold”

magnitudes118, but my work begins to identify specific cellular mechanisms mediating this
conversion in neuronal phenotypes. Finally, the work reported here discovered the unexpected
finding that diabetes completely abrogates the mRNA granule response in the neurons of the
focal ischemic brain. This adds an additional effect of diabetes on brain that clearly will
contribute to worsened outcome in the diabetic brain after stroke and opens up a new line of
investigation into how diabetes exerts adverse affect on ribonomic pathways in neurons.
As the work I did relied on the work of other researchers before me, I sincerely hope my
work can be a stepping stone for future studies that will lead to a clear and full understanding of
the insidious effects of both diabetes and stroke and lead one day to successful treatments that
can alleviate the pain and suffering of both stroke victims and diabetic patients.
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ABSTRACT
MECHANISMS OF TRANSLATION ARREST FOLLOWING FOCAL BRAIN
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Diabetes affects 25 million and stroke affects ¾ million people a year in the USA.
Diabetes increases the risk of stroke and worsens stroke outcome, but the causes for this are not
fully known. Neurons destined to die following brain ischemia undergo a persistent translation
arrest that prevents successful expression of protective cellular responses. Recent work has
revealed the translation arrest following global ischemia is due to sequestration of mRNA in the
form of mRNA granules away from ribosomal subunits, thereby precluding translation.

I

hypothesize that mRNA granules form during focal brain ischemia and this effect is worsened in
diabetics subjected to focal brain ischemia. MCAO was performed for durations ranging from 28 hr and mRNA granules assessed by fluorescence in situ histochemistry. Long Evans rats
showed strong mRNA granule formation in penumbra at 2 hr ischemia but not Wistar rats. In the
Long Evans strain, the volume of brain containing neurons expressing mRNA granules
decreased exponentially from 2 to 8 hr focal brain ischemia such that no mRNA granules were
detected at 8 hr ischemia. Colocalization studies of mRNA granules with a panel of organelle
and mRNA binding protein markers showed these to colocalize with PABP, HuR and NeuN.
mRNA granules did not colocalize with markers of ribosomal subunits, endoplasmic reticulum,
cis- and trans-Golgi networks, mitochondria, microtubules, intermediate filaments, stress
granules, processing bodies or the HuR accessory proteins APRIL and pp32.

Diabetes

completely abrogated the formation of mRNA granules following any duration of focal ischemia

111

tested. Thus, mRNA granules form in penumbral neurons following focal brain ischemia and
mediate translation arrest in these neurons. This response is inhibited by diabetes. Since mRNA
granules are part of the ribonomic regulation of neuronal stress responses, their inhibition by
diabetes provides an additional mechanism whereby diabetes worsens outcome after focal brain
ischemia.

112

AUTOBIOGRAPHICAL STATEMENT

EDUCATION
Wayne State University

Detroit, MI

Ph.D in Physiology

planned graduation date:

August 2011

Wayne State University
Masters in Basic Medical Sciences

December 2004

Thesis: The Impact of Hypertension in Type-1 Diabetic Nephropathy
Advisor: Dr. David Lawson

University of Michigan

Ann Arbor, MI

BA in Sociology

May 1997

PUBLICATIONS
Jamison JT. Lewis MK, Kreipke CW. Rafols J. DeGracia DJ. Polyadenylated mRNA staining
reveals distinct neuronal phenotypes following endothelin 1, focal brain ischemia, and
global brain ischemia/ reperfusion. Neurological Research 2011;33(2):145-161.
DeGracia DJ, Jamison JT, Szymanski JJ, Lewis MK. Translation arrest and ribonomics in postischemic brain: layers and layers of players. J Neurochem. 2008;106(6):2288-301.
Jamison JT, Kayali F, Rudolph J, Marshall M, Kimball SR, DeGracia DJ.

Persistent

redistribution of poly-adenylated mRNAs correlates with translation arrest and cell death
following global brain ischemia and reperfusion. Neuroscience. 2008;154(2):504-20.
Roberts GG, Di Loreto MJ, Marshall M, Wang J, DeGracia DJ. Hippocampal cellular stress
responses after global brain ischemia and reperfusion.
2007;9(12):2265-75.

Antioxid Redox Signal.

